{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:08Z","timestamp":1792643888102,"version":"4.5.0"},"reference-count":307,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Research Foundation of Republic of Korea","award":["RS-2024-00451538"],"award-info":[{"award-number":["RS-2024-00451538"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12272-026-01640-x","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:58Z","timestamp":1791346498000},"page":"1175-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting histamine signaling: repurposing antihistamines for cancer chemotherapy and immunotherapy"],"prefix":"10.1007","volume":"49","author":[{"given":"Manoj Kumar","family":"Baniya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-2897","authenticated-orcid":false,"given":"Kyung-Soo","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1640_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1182\/blood-2016-09-736686","volume":"129","author":"Y Abaza","year":"2017","unstructured":"Abaza Y, Kantarjian H, Garcia-Manero G, Estey E, Borthakur G, Jabbour E, Faderl S, O\u2019brien S, Wierda W, Pierce S, Brandt M, Mccue D, Luthra R, Patel K, Kornblau S, Kadia T, Daver N, Dinardo C, Jain N, Verstovsek S, Ferrajoli A, Andreeff M, Konopleva M, Estrov Z, Foudray M, Mccue D, Cortes J, Ravandi F (2017) Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. blood. J Am Soc Hematol 129:1275\u20131283. https:\/\/doi.org\/10.1182\/blood-2016-09-736686","journal-title":"J Am Soc Hematol"},{"key":"1640_CR2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1136\/gut.35.11.1632","volume":"35","author":"WJ Adams","year":"1994","unstructured":"Adams WJ, Lawson JA, Morris DL (1994a) Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35:1632\u20131636. https:\/\/doi.org\/10.1136\/gut.35.11.1632","journal-title":"Gut"},{"key":"1640_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1445-2197.1994.tb04562.x","volume":"64","author":"WJ Adams","year":"1994","unstructured":"Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L (1994b) Cimetidine preserves non-specific immune function after colonic resection for cancer. Aust N Z J Surg 64:847\u2013852. https:\/\/doi.org\/10.1111\/j.1445-2197.1994.tb04562.x","journal-title":"Aust N Z J Surg"},{"key":"1640_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0378-4347(97)00083-2","volume":"693","author":"DA Adams","year":"1997","unstructured":"Adams DA, Murray S, Clifford CP, Rendell NB, Davies DS, Taylor GW (1997) Analysis of terfenadine in human plasma using microbore high-performace liquid chromatography-electrospray ionisation mass spectrometry. J Chromatogr B Biomed Sci Appl 693:345\u2013351. https:\/\/doi.org\/10.1016\/s0378-4347(97)00083-2","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"1640_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.gendis.2022.12.013","volume":"11","author":"D Ajmeera","year":"2024","unstructured":"Ajmeera D, Ajumeera R (2024) Drug repurposing: a novel strategy to target cancer stem cells and therapeutic resistance. Genes Dis 11:148\u2013175. https:\/\/doi.org\/10.1016\/j.gendis.2022.12.013","journal-title":"Genes Dis"},{"key":"1640_CR6","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.2147\/ijn.S483667","volume":"19","author":"IH Ali","year":"2024","unstructured":"Ali IH, Al-Tabakha MM, Khalil IA (2024) Loratadine loaded chitosan tannic acid nanoparticles as anti-proliferative agent against breast cancer: in-silico, in-vitro and cell studies. Int J Nanomedicine 19:12483\u201312504. https:\/\/doi.org\/10.2147\/ijn.S483667","journal-title":"Int J Nanomedicine"},{"key":"1640_CR7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.bbagen.2016.06.016","volume":"1860","author":"N Alonso","year":"2016","unstructured":"Alonso N, Diaz Nebreda A, Monczor F, Gutkind JS, Davio C, Fernandez N, Shayo C (2016) PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells. Biochim Biophys Acta 1860:1998\u20132007. https:\/\/doi.org\/10.1016\/j.bbagen.2016.06.016","journal-title":"Biochim Biophys Acta"},{"key":"1640_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1078155220975825","volume":"27","author":"GG Amare","year":"2021","unstructured":"Amare GG, Meharie BG, Belayneh YM (2021) A drug repositioning success: the repositioned therapeutic applications and mechanisms of action of thalidomide. J Oncol Pharm Pract 27:673\u2013678. https:\/\/doi.org\/10.1177\/1078155220975825","journal-title":"J Oncol Pharm Pract"},{"key":"1640_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2017.07.021","volume":"124","author":"L An","year":"2017","unstructured":"An L, Li DD, Chu HX, Zhang Q, Wang CL, Fan YH, Song Q, Ma HD, Feng F, Zhao QC (2017) Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and notch reversal. Pharmacol Res 124:105\u2013115. https:\/\/doi.org\/10.1016\/j.phrs.2017.07.021","journal-title":"Pharmacol Res"},{"key":"1640_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/1535-7163.Mct-18-1406","volume":"18","author":"A Anand","year":"2019","unstructured":"Anand A, Liu B, Dicroce Giacobini J, Maeda K, Rohde M, J\u00e4\u00e4ttel\u00e4 M (2019) Cell death induced by cationic amphiphilic drugs depends on lysosomal Ca(2+) release and cyclic AMP. Mol Cancer Ther 18:1602\u20131614. https:\/\/doi.org\/10.1158\/1535-7163.Mct-18-1406","journal-title":"Mol Cancer Ther"},{"key":"1640_CR11","doi-asserted-by":"crossref","unstructured":"Awasthi DK and Awasthi G (2020) Autocoids: A Brief Review. WJPMR 6: 369-377.","DOI":"10.18811\/ijpen.v6i02.10"},{"key":"1640_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1158\/2326-6066.Cir-16-0382","volume":"5","author":"E Aydin","year":"2017","unstructured":"Aydin E, Johansson J, Nazir FH, Hellstrand K, Martner A (2017) Role of NOX2-derived reactive oxygen species in NK cell-mediated control of murine melanoma metastasis. Cancer Immunol Res 5:804\u2013811. https:\/\/doi.org\/10.1158\/2326-6066.Cir-16-0382","journal-title":"Cancer Immunol Res"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12032-024-02437-y","volume":"41","author":"H Azimi","year":"2024","unstructured":"Azimi H, Jafari A, Maralani M, Davoodi H (2024) The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets. Med Oncol 41:190. https:\/\/doi.org\/10.1007\/s12032-024-02437-y","journal-title":"Med Oncol"},{"key":"1640_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/14737140.2023.2157265","volume":"23","author":"E Bakhtiari","year":"2023","unstructured":"Bakhtiari E, Moazzen N, Amirabadi A, Ahanchian H (2023) The clinical relationship between histamine-1 receptor antagonists and risk of cancer: a systematic review and meta-analysis. Expert Rev Anticancer Ther 23:87\u201394. https:\/\/doi.org\/10.1080\/14737140.2023.2157265","journal-title":"Expert Rev Anticancer Ther"},{"key":"1640_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1418266","volume":"15","author":"MK Baniya","year":"2024","unstructured":"Baniya MK, Kim EH, Chun KS (2024) Terfenadine, a histamine H1 receptor antagonist, induces apoptosis by suppressing STAT3 signaling in human colorectal cancer HCT116 cells. Front Pharmacol 15:1418266. https:\/\/doi.org\/10.3389\/fphar.2024.1418266","journal-title":"Front Pharmacol"},{"key":"1640_CR16","first-page":"639","volume":"44","author":"J Bartholeyns","year":"1984","unstructured":"Bartholeyns J, Bouclier M (1984) Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res 44:639\u2013645","journal-title":"Cancer Res"},{"key":"1640_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1610-0387.2010.07346.x","volume":"8","author":"W B\u00e4umer","year":"2010","unstructured":"B\u00e4umer W, Rossbach K (2010) Histamine as an immunomodulator. JDDG J Dtsch Dermatol Ges 8:495\u2013504. https:\/\/doi.org\/10.1111\/j.1610-0387.2010.07346.x.\u00a0","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"1640_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0091-6749(84)90353-1","volume":"73","author":"DJ Beer","year":"1984","unstructured":"Beer DJ, Rocklin RE (1984) Histamine-induced suppressor-cell activity. J Allergy Clin Immunol 73:439\u2013452. https:\/\/doi.org\/10.1016\/0091-6749(84)90353-1","journal-title":"J Allergy Clin Immunol"},{"key":"1640_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14715\/cmb\/2017.63.12.4","volume":"63","author":"G Bernal-Ramos","year":"2017","unstructured":"Bernal-Ramos G, Hern\u00e1ndez-Gallegos E, Vera E, Ch\u00e1vez-L\u00f3pez MG, Z\u00fa\u00f1iga-Garc\u00eda V, S\u00e1nchez-P\u00e9rez Y, Garrido E, Camacho J (2017) Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether \u00e0-go-go-1 potassium channels. Cell Mol Biol (Noisy-Le-Grand) 63:11\u201313. https:\/\/doi.org\/10.14715\/cmb\/2017.63.12.4","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12325-021-01999-x","volume":"39","author":"MS Blaiss","year":"2022","unstructured":"Blaiss MS, Bernstein JA, Kessler A, Pines JM, Camargo CA Jr., Fulgham P, Haumschild R, Rupp K, Tyler T, Moellman J (2022) The role of cetirizine in the changing landscape of IV antihistamines: a narrative review. Adv Ther 39:178\u2013192. https:\/\/doi.org\/10.1007\/s12325-021-01999-x","journal-title":"Adv Ther"},{"key":"1640_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2022.08.009","volume":"350","author":"B Bogaert","year":"2022","unstructured":"Bogaert B, Sauvage F, Guagliardo R, Muntean C, Nguyen VP, Pottie E, Wels M, Minnaert AK, De Rycke R, Yang Q, Peer D, Sanders N, Remaut K, Paulus YM, Stove C, De Smedt SC, Raemdonck K (2022) A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. J Control Release 350:256\u2013270. https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.009","journal-title":"J Control Release"},{"key":"1640_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/scbi.2000.0301","volume":"10","author":"E Bolton","year":"2000","unstructured":"Bolton E, King J, Morris DL (2000) H2-antagonists in the treatment of colon and breast cancer. Semin Cancer Biol 10:3\u201310. https:\/\/doi.org\/10.1006\/scbi.2000.0301","journal-title":"Semin Cancer Biol"},{"key":"1640_CR23","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1398-9995.2009.02115.x","volume":"64","author":"J Bousquet","year":"2009","unstructured":"Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Lorber R, Zuberbier T (2009) Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy 64:1516\u20131523. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02115.x","journal-title":"Allergy"},{"key":"1640_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9524075","author":"A Branco","year":"2018","unstructured":"Branco A, Yoshikawa FSY, Pietrobon AJ, Sato MN (2018) Role of histamine in modulating the immune response and inflammation. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2018\/9524075","journal-title":"Mediators Inflamm"},{"key":"1640_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"1640_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood-2005-10-4073","volume":"108","author":"M Brune","year":"2006","unstructured":"Brune M, Castaigne S, Catalano J, Gehlsen K, Ho AD, Hofmann WK, Hogge DE, Nilsson B, Or R, Romero AI, Rowe JM, Simonsson B, Spearing R, Stadtmauer EA, Szer J, Wallhult E, Hellstrand K (2006) Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial. Blood 108:88\u201396. https:\/\/doi.org\/10.1182\/blood-2005-10-4073","journal-title":"Blood"},{"key":"1640_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ejca.2013.12.025","volume":"50","author":"WK Cai","year":"2014","unstructured":"Cai WK, Hu J, Li T, Meng JR, Ma X, Yin SJ, Zhao CH, He GH, Xu GL (2014) Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-\u03b21 signalling pathway in non-small cell lung cancer. Eur J Cancer 50:1195\u20131206. https:\/\/doi.org\/10.1016\/j.ejca.2013.12.025","journal-title":"Eur J Cancer"},{"key":"1640_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.14309\/ajg.0000000000001310","volume":"116","author":"CR Cardwell","year":"2021","unstructured":"Cardwell CR, Mcdowell RD, Hughes CM, Hicks B, Murchie P (2021) Exposure to ranitidine and risk of bladder cancer: a nested case-control study. Am J Gastroenterol 116:1612\u20131619. https:\/\/doi.org\/10.14309\/ajg.0000000000001310","journal-title":"Am J Gastroenterol"},{"key":"1640_CR29","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.2147\/ott.S144506","volume":"10","author":"MG Ch\u00e1vez-L\u00f3pez","year":"2017","unstructured":"Ch\u00e1vez-L\u00f3pez MG, Z\u00fa\u00f1iga-Garc\u00eda V, Hern\u00e1ndez-Gallegos E, Vera E, Chasiquiza-Anchatu\u00f1a CA, Viteri-Y\u00e1nez M, Sanchez-Ramos J, Garrido E, Camacho J (2017) The combination astemizole-gefitinib as a potential therapy for human lung cancer. Onco Targets Ther 10:5795\u20135803. https:\/\/doi.org\/10.2147\/ott.S144506","journal-title":"Onco Targets Ther"},{"key":"1640_CR30","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.3892\/ol.2018.9310","volume":"16","author":"J Chen","year":"2018","unstructured":"Chen J, Hu XY (2018) Inhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway. Oncol Lett 16:4921\u20134928. https:\/\/doi.org\/10.3892\/ol.2018.9310","journal-title":"Oncol Lett"},{"key":"1640_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccell.2021.11.007","volume":"40","author":"S Chen","year":"2022","unstructured":"Chen S, Luster AD (2022) Antihistamines for cancer immunotherapy: more than just treating allergies. Cancer Cell 40:9\u201311. https:\/\/doi.org\/10.1016\/j.ccell.2021.11.007","journal-title":"Cancer Cell"},{"key":"1640_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/mc.20165","volume":"45","author":"JS Chen","year":"2006","unstructured":"Chen JS, Lin SY, Tso WL, Yeh GC, Lee WS, Tseng H, Chen LC, Ho YS (2006) Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2\/M phase cell-cycle arrest and apoptosis. Mol Carcinog 45:461\u2013478. https:\/\/doi.org\/10.1002\/mc.20165","journal-title":"Mol Carcinog"},{"key":"1640_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Liu G, Wang X, Hong H, Li T, Li L, Wang H, Xie J, Li B, Li T, Lu D, Zhang Y, Zhao H, Yao C, Wen K, Li T, Chen J, Wu S, He K, Zhang WN, Zhao J, Wang N, Han Q, Xia Q, Qi J, Chen J, Zhou T, Man J, Zhang XM, Li AL, Pan X (2022) Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell 29:1531-1546.e7. https:\/\/doi.org\/10.1016\/j.stem.2022.09.009","journal-title":"Cell Stem Cell"},{"key":"1640_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2022.07.006","volume":"174","author":"CH Chiang","year":"2022","unstructured":"Chiang CH, Chiang CH, Peng CY, Hsia YP, See XY, Horng CS, Chang YC, Shen XE, Wang SS, Tsai TC, Chen YJ, Ma KS, Chen BS, Luan YZ, Tay ST, Shen CH, Chung KC, Chiang CH, Peng CM (2022) Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitors. Eur J Cancer 174:1\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2022.07.006","journal-title":"Eur J Cancer"},{"key":"1640_CR35","doi-asserted-by":"publisher","first-page":"e21078","DOI":"10.1200\/JCO.2023.41.16_suppl.e21078","volume":"41","author":"CH Chiang","year":"2023","unstructured":"Chiang CH, Chiang CH, See XY, Hsia Y, Peng C-Y, Horng C-S, Chang Y-C, Wang S-S, Chiang CH, Peng C-M, Shiah H-S (2023) The impact of cationic amphiphilic antihistamines on patients with lung cancer receiving immunotherapy. J Clin Oncol 41:e21078\u2013e21078. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e21078","journal-title":"J Clin Oncol"},{"key":"1640_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12029-023-00969-6","volume":"55","author":"CH Chiang","year":"2024","unstructured":"Chiang CH, Chiang CH, Hsia YP, Chen BS, Jaroenlapnopparat A, Chiang CH, Peng CM (2024) The efficacy of cationic amphiphilic antihistamines on outcomes of patients with pancreatic ductal adenocarcinoma. J Gastrointest Cancer 55:175\u2013177. https:\/\/doi.org\/10.1007\/s12029-023-00969-6","journal-title":"J Gastrointest Cancer"},{"key":"1640_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5495","author":"MH Chien","year":"2025","unstructured":"Chien MH, Hung WY, Lai TC, Tsai CH, Lee KL, Hsieh FK, Lee WJ, Chang JH (2025) The off-target effect of loratadine triggers autophagy-mediated apoptosis in lung adenocarcinoma cells by deactivating JNK, p38, and STAT3 signaling through both PP2A-dependent and independent pathways. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2025.5495","journal-title":"Int J Mol Med"},{"key":"1640_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jlb.Mr0318-097r","volume":"105","author":"D Chraa","year":"2019","unstructured":"Chraa D, Naim A, Olive D, Badou A (2019) T lymphocyte subsets in cancer immunity: friends or foes. J Leukoc Biol 105:243\u2013255. https:\/\/doi.org\/10.1002\/jlb.Mr0318-097r","journal-title":"J Leukoc Biol"},{"key":"1640_CR39","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.semcancer.2021.11.006","volume":"86","author":"KS Chun","year":"2022","unstructured":"Chun KS, Kim DH, Raut PK, Surh YJ (2022) Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 86:1008\u20131032. https:\/\/doi.org\/10.1016\/j.semcancer.2021.11.006","journal-title":"Semin Cancer Biol"},{"key":"1640_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116259","volume":"228","author":"KS Chun","year":"2024","unstructured":"Chun KS, Kim EH, Kim DH, Song NY, Kim W, Na HK, Surh YJ (2024) Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: an update. Biochem Pharmacol 228:116259. https:\/\/doi.org\/10.1016\/j.bcp.2024.116259","journal-title":"Biochem Pharmacol"},{"key":"1640_CR41","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1158\/1078-0432.Ccr-05-0675","volume":"11","author":"F Cianchi","year":"2005","unstructured":"Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, Bani D, Messerini L, Fabbroni V, Perigli G, Capaccioli S, Masini E (2005) The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res 11:6807\u20136815. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-0675","journal-title":"Clin Cancer Res"},{"key":"1640_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/bf02005757","volume":"43","author":"GP Cricco","year":"1994","unstructured":"Cricco GP, Davio CA, Martin G, Engel N, Fitzsimons CP, Bergoc RM, Rivera ES (1994) Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions 43:17\u201320. https:\/\/doi.org\/10.1007\/bf02005757","journal-title":"Agents Actions"},{"key":"1640_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1469-185X.2009.00105.x","volume":"85","author":"E Crivellato","year":"2010","unstructured":"Crivellato E, Ribatti D (2010) The mast cell: an evolutionary perspective. Biol Rev Camb Philos Soc 85:347\u2013360. https:\/\/doi.org\/10.1111\/j.1469-185X.2009.00105.x","journal-title":"Biol Rev Camb Philos Soc"},{"key":"1640_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/d41573-021-00204-6","volume":"21","author":"M Cully","year":"2022","unstructured":"Cully M (2022) Anti-histamines boost immunotherapy. Nat Rev Drug Discov 21:17. https:\/\/doi.org\/10.1038\/d41573-021-00204-6","journal-title":"Nat Rev Drug Discov"},{"key":"1640_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/igc.0000000000000151","volume":"24","author":"C-L\u00f3pez M De Guadalupe","year":"2014","unstructured":"de Guadalupe C-L\u00f3pez M, Hern\u00e1ndez-Gallegos E, V\u00e1zquez-S\u00e1nchez AY, Gariglio P, Camacho J (2014) Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells. Int J Gynecol Cancer 24:824\u2013828. https:\/\/doi.org\/10.1097\/igc.0000000000000151","journal-title":"Int J Gynecol Cancer"},{"key":"1640_CR46","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1007\/s13277-015-3299-0","volume":"36","author":"M De Guadalupe Ch\u00e1vez-L\u00f3pez","year":"2015","unstructured":"de Guadalupe Ch\u00e1vez-L\u00f3pez M, P\u00e9rez-Carre\u00f3n JI, Zu\u00f1iga-Garc\u00eda V, D\u00edaz-Ch\u00e1vez J, Herrera LA, Caro-S\u00e1nchez CH, Acu\u00f1a-Mac\u00edas I, Gariglio P, Hern\u00e1ndez-Gallegos E, Chiliquinga AJ, Camacho J (2015) Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. Tumour Biol 36:6149\u20136158. https:\/\/doi.org\/10.1007\/s13277-015-3299-0","journal-title":"Tumour Biol"},{"key":"1640_CR47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/bph.12989","volume":"172","author":"A Deiteren","year":"2015","unstructured":"Deiteren A, De Man JG, Pelckmans PA, De Winter BY (2015) Histamine H4 receptors in the gastrointestinal tract. Br J Pharmacol 172:1165\u20131178. https:\/\/doi.org\/10.1111\/bph.12989","journal-title":"Br J Pharmacol"},{"key":"1640_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007814.pub2","author":"S Deva","year":"2012","unstructured":"Deva S, Jameson M (2012) Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007814.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1640_CR49","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1158\/0008-5472.Can-08-2036","volume":"69","author":"L D\u00edaz","year":"2009","unstructured":"D\u00edaz L, Ceja-Ochoa I, Restrepo-Angulo I, Larrea F, Avila-Ch\u00e1vez E, Garc\u00eda-Becerra R, Borja-Cacho E, Barrera D, Ahumada E, Gariglio P, Alvarez-Rios E, Ocadiz-Delgado R, Garcia-Villa E, Hern\u00e1ndez-Gallegos E, Camacho-Arroyo I, Morales A, Ordaz-Rosado D, Garc\u00eda-Latorre E, Escamilla J, S\u00e1nchez-Pe\u00f1a LC, Saqui-Salces M, Gamboa-Dominguez A, Vera E, Uribe-Ram\u00edrez M, Murbarti\u00e1n J, Ortiz CS, Rivera-Guevara C, De Vizcaya-Ruiz A, Camacho J (2009) Estrogens and human papilloma virus oncogenes regulate human ether-\u00e0-go-go-1 potassium channel expression. Cancer Res 69:3300\u20133307. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-2036","journal-title":"Cancer Res"},{"key":"1640_CR50","doi-asserted-by":"publisher","first-page":"52491","DOI":"10.1074\/jbc.M310712200","volume":"278","author":"SH Diks","year":"2003","unstructured":"Diks SH, Hardwick JC, Diab RM, Van Santen MM, Versteeg HH, Van Deventer SJH, Richel DJ, Peppelenbosch MP (2003) Activation of the canonical beta-catenin pathway by histamine *. J Biol Chem 278:52491\u201352496. https:\/\/doi.org\/10.1074\/jbc.M310712200","journal-title":"J Biol Chem"},{"key":"1640_CR51","doi-asserted-by":"publisher","first-page":"36234","DOI":"10.1074\/jbc.M801830200","volume":"283","author":"BR Downie","year":"2008","unstructured":"Downie BR, S\u00e1nchez A, Kn\u00f6tgen H, Contreras-Jurado C, Gymnopoulos M, Weber C, St\u00fchmer W, Pardo LA (2008) Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem 283:36234\u201336240. https:\/\/doi.org\/10.1074\/jbc.M801830200","journal-title":"J Biol Chem"},{"key":"1640_CR52","first-page":"191","volume":"1","author":"SJ Dwerryhouse","year":"1999","unstructured":"Dwerryhouse SJ, Soon Lee C, King J, Magarey C, Schwartz P, Morris DL (1999) Cimetidine does not influence TIL in breast cancer. Int J Surg Investig 1:191\u2013194","journal-title":"Int J Surg Investig"},{"key":"1640_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-018-8720-1","volume":"56","author":"D Elieh Ali Komi","year":"2019","unstructured":"Elieh Ali Komi D, Bjermer L (2019) Mast cell-mediated orchestration of the immune responses in human allergic asthma: current insights. Clin Rev Allergy Immunol 56:234\u2013247. https:\/\/doi.org\/10.1007\/s12016-018-8720-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"1640_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ebiom.2016.06.013","volume":"9","author":"AM Ellegaard","year":"2016","unstructured":"Ellegaard AM, Dehlendorff C, Vind AC, Anand A, Cederkvist L, Petersen NHT, Nylandsted J, Stenvang J, Mellemgaard A, \u00d8sterlind K, Friis S, J\u00e4\u00e4ttel\u00e4 M (2016) Repurposing cationic amphiphilic antihistamines for cancer treatment. EBioMedicine 9:130\u2013139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.06.013","journal-title":"EBioMedicine"},{"key":"1640_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1365-2230.1999.00397.x","volume":"24","author":"U Enomoto","year":"1999","unstructured":"Enomoto U, Kusakabe H, Matsumura T, Kuno T, Tamai H, Kiyokane K (1999) Diffuse cutaneous mastocytosis responding to cyproheptadine. Clin Exp Dermatol 24:16\u201318. https:\/\/doi.org\/10.1046\/j.1365-2230.1999.00397.x","journal-title":"Clin Exp Dermatol"},{"key":"1640_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/cad.0000000000001498","volume":"35","author":"E Eylemer Mocan","year":"2024","unstructured":"Eylemer Mocan E, Yeked\u00fcz E, Karata\u015f G, Yazgan SC, K\u00f6ksoy EB, \u00c7ay \u015eenler F, Utkan G, Demirkazik A, Akbulut H, \u00dcr\u00fcn Y (2024) Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients. Anticancer Drugs 35:190\u2013194. https:\/\/doi.org\/10.1097\/cad.0000000000001498","journal-title":"Anticancer Drugs"},{"key":"1640_CR57","doi-asserted-by":"publisher","first-page":"188.e9","DOI":"10.1016\/j.urolonc.2024.12.267","volume":"43","author":"G Fallara","year":"2025","unstructured":"Fallara G, Belladelli F, Robesti D, Malavaud B, Tholomier C, Mokkapati S, Montorsi F, Dinney CP, Msaouel P, Martini A (2025) Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211. Urol Oncol 43:188.e9-188.e17. https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.267","journal-title":"Urol Oncol"},{"key":"1640_CR58","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/s1471-4906(01)02050-6","volume":"22","author":"A Falus","year":"2001","unstructured":"Falus A, Hegyesi H, L\u00e1z\u00e1r-Moln\u00e1r E, P\u00f3s Z, L\u00e1szl\u00f3 V, Darvas Z (2001) Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 22:648\u2013652. https:\/\/doi.org\/10.1016\/s1471-4906(01)02050-6","journal-title":"Trends Immunol"},{"key":"1640_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.12.008","volume":"172","author":"AI Faustino-Rocha","year":"2017","unstructured":"Faustino-Rocha AI, Ferreira R, Gama A, Oliveira PA, Ginja M (2017) Antihistamines as promising drugs in cancer therapy. Life Sci 172:27\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2016.12.008","journal-title":"Life Sci"},{"key":"1640_CR60","unstructured":"FDA (2019) Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products. Guidance for Industry."},{"key":"1640_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s1471-4906(01)02156-1","volume":"23","author":"F F\u00e9ger","year":"2002","unstructured":"F\u00e9ger F, Varadaradjalou S, Gao Z, Abraham SN, Arock M (2002) The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol 23:151\u2013158. https:\/\/doi.org\/10.1016\/s1471-4906(01)02156-1","journal-title":"Trends Immunol"},{"key":"1640_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007180","author":"YM Feng","year":"2012","unstructured":"Feng YM, Feng CW, Chen SC, Hsu CD (2012) Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2012-007180","journal-title":"BMJ Case Rep"},{"key":"1640_CR63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12885-015-1137-9","volume":"15","author":"YM Feng","year":"2015","unstructured":"Feng Y-M, Feng C-W, Chen S-Y, Hsieh H-Y, Chen Y-H, Hsu C-D (2015a) Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase. BMC Cancer 15:134. https:\/\/doi.org\/10.1186\/s12885-015-1137-9","journal-title":"BMC Cancer"},{"key":"1640_CR64","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/jjco\/hyv007","volume":"45","author":"YM Feng","year":"2015","unstructured":"Feng YM, Feng CW, Lu CL, Lee MY, Chen CY, Chen SC (2015c) Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients. Jpn J Clin Oncol 45:336\u2013342. https:\/\/doi.org\/10.1093\/jjco\/hyv007","journal-title":"Jpn J Clin Oncol"},{"key":"1640_CR65","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.18632\/oncotarget.6543","volume":"7","author":"P Fern\u00e1ndez-Nogueira","year":"2016","unstructured":"Fern\u00e1ndez-Nogueira P, Bragado P, Almendro V, Ametller E, Rios J, Choudhury S, Mancino M, Gasc\u00f3n P (2016) Differential expression of neurogenes among breast cancer subtypes identifies high risk patients. Oncotarget 7:5313\u20135326. https:\/\/doi.org\/10.18632\/oncotarget.6543","journal-title":"Oncotarget"},{"key":"1640_CR66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2018.03.014","volume":"424","author":"P Fern\u00e1ndez-Nogueira","year":"2018","unstructured":"Fern\u00e1ndez-Nogueira P, Noguera-Castells A, Fuster G, Recalde-Percaz L, Moragas N, L\u00f3pez-Plana A, Enreig E, Jauregui P, Carb\u00f3 N, Almendro V, Gasc\u00f3n P, Bragado P, Mancino M (2018) Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer Lett 424:70\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.014","journal-title":"Cancer Lett"},{"key":"1640_CR67","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.4049\/jimmunol.0802509","volume":"183","author":"NA Forward","year":"2009","unstructured":"Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW (2009) Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction. J Immunol 183:3014\u20133022. https:\/\/doi.org\/10.4049\/jimmunol.0802509","journal-title":"J Immunol"},{"key":"1640_CR68","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1541-7786.Mcr-09-0261","volume":"7","author":"H Francis","year":"2009","unstructured":"Francis H, Onori P, Gaudio E, Franchitto A, Demorrow S, Venter J, Kopriva S, Carpino G, Mancinelli R, White M, Meng F, Vetuschi A, Sferra R, Alpini G (2009) H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. Mol Cancer Res 7:1704\u20131713. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-09-0261","journal-title":"Mol Cancer Res"},{"key":"1640_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jaci.2013.01.013","volume":"132","author":"R Frei","year":"2013","unstructured":"Frei R, Ferstl R, Konieczna P, Ziegler M, Simon T, Rugeles TM, Mailand S, Watanabe T, Lauener R, Akdis CA, O\u2019mahony L (2013) Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol 132:194\u2013204. https:\/\/doi.org\/10.1016\/j.jaci.2013.01.013","journal-title":"J Allergy Clin Immunol"},{"key":"1640_CR70","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/all.14273","volume":"75","author":"I Fritz","year":"2020","unstructured":"Fritz I, Wagner P, Bottai M, Eriksson H, Ingvar C, Krakowski I, Nielsen K, Olsson H (2020a) Desloratadine and loratadine use associated with improved melanoma survival. Allergy 75:2096\u20132099. https:\/\/doi.org\/10.1111\/all.14273","journal-title":"Allergy"},{"key":"1640_CR71","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/0284186x.2020.1769185","volume":"59","author":"I Fritz","year":"2020","unstructured":"Fritz I, Wagner P, Broberg P, Einefors R, Olsson H (2020b) Desloratadine and loratadine stand out among common H(1)-antihistamines for association with improved breast cancer survival. Acta Oncol 59:1103\u20131109. https:\/\/doi.org\/10.1080\/0284186x.2020.1769185","journal-title":"Acta Oncol"},{"key":"1640_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101029","volume":"14","author":"I Fritz","year":"2021","unstructured":"Fritz I, Wagner P, Olsson H (2021) Improved survival in several cancers with use of H(1)-antihistamines desloratadine and loratadine. Transl Oncol 14:101029. https:\/\/doi.org\/10.1016\/j.tranon.2021.101029","journal-title":"Transl Oncol"},{"key":"1640_CR73","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1245\/s10434-016-5702-5","volume":"24","author":"H Fu","year":"2017","unstructured":"Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang Z, Xie H, Dai B, Xu J, Ye D (2017) Tumor infiltrating mast cells (TIMs) confers a marked survival advantage in nonmetastatic clear-cell renal cell carcinoma. Ann Surg Oncol 24:1435\u20131442. https:\/\/doi.org\/10.1245\/s10434-016-5702-5","journal-title":"Ann Surg Oncol"},{"key":"1640_CR74","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","journal-title":"Nat Immunol"},{"key":"1640_CR75","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.ajpath.2017.06.011","volume":"187","author":"C Gao","year":"2017","unstructured":"Gao C, Ganesh BP, Shi Z, Shah RR, Fultz R, Major A, Venable S, Lugo M, Hoch K, Chen X, Haag A, Wang TC, Versalovic J (2017) Gut microbe-mediated suppression of inflammation-associated colon carcinogenesis by luminal histamine production. Am J Pathol 187:2323\u20132336. https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.011","journal-title":"Am J Pathol"},{"key":"1640_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.yexcr.2009.11.008","volume":"316","author":"R Garc\u00eda-Becerra","year":"2010","unstructured":"Garc\u00eda-Becerra R, D\u00edaz L, Camacho J, Barrera D, Ordaz-Rosado D, Morales A, Ortiz CS, Avila E, Bargallo E, Arrecillas M, Halhali A, Larrea F (2010) Calcitriol inhibits ether-\u00e0 go-go potassium channel expression and cell proliferation in human breast cancer cells. Exp Cell Res 316:433\u2013442. https:\/\/doi.org\/10.1016\/j.yexcr.2009.11.008","journal-title":"Exp Cell Res"},{"key":"1640_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/bf02142587","volume":"23","author":"M Garcia-Caballero","year":"1988","unstructured":"Garcia-Caballero M, Neugebauer E, Campos R, Nunez De Castro I, Vara-Thorbeck C (1988) Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 23:357\u2013360. https:\/\/doi.org\/10.1007\/bf02142587","journal-title":"Agents Actions"},{"key":"1640_CR78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/187152011795347513","volume":"11","author":"J Garc\u00eda-Quiroz","year":"2011","unstructured":"Garc\u00eda-Quiroz J, Camacho J (2011) Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem 11:307\u2013314. https:\/\/doi.org\/10.2174\/187152011795347513","journal-title":"Anticancer Agents Med Chem"},{"key":"1640_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045063","volume":"7","author":"J Garc\u00eda-Quiroz","year":"2012","unstructured":"Garc\u00eda-Quiroz J, Garc\u00eda-Becerra R, Barrera D, Santos N, Avila E, Ordaz-Rosado D, Rivas-Su\u00e1rez M, Halhali A, Rodr\u00edguez P, Gamboa-Dom\u00ednguez A, Medina-Franco H, Camacho J, Larrea F, D\u00edaz L (2012) Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy. PLoS ONE 7:e45063. https:\/\/doi.org\/10.1371\/journal.pone.0045063","journal-title":"PLoS ONE"},{"key":"1640_CR80","doi-asserted-by":"publisher","first-page":"186","DOI":"10.24875\/ric.18002840","volume":"71","author":"J Garc\u00eda-Quiroz","year":"2019","unstructured":"Garc\u00eda-Quiroz J, Gonz\u00e1lez-Gonz\u00e1lez ME, D\u00edaz L, Ordaz-Rosado D, Segovia-Mendoza M, Prado-Garc\u00eda H, Larrea F, Garc\u00eda-Becerra R (2019) Astemizole, an inhibitor of ether-\u00e0-go-go-1 potassium channel, increases the activity of the tyrosine kinase inhibitor gefitinib in breast cancer cells. Rev Invest Clin 71:186\u2013194. https:\/\/doi.org\/10.24875\/ric.18002840","journal-title":"Rev Invest Clin"},{"key":"1640_CR81","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1067\/mai.2001.114239","volume":"107","author":"RS Geha","year":"2001","unstructured":"Geha RS, Meltzer EO (2001) Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 107:751\u2013762. https:\/\/doi.org\/10.1067\/mai.2001.114239","journal-title":"J Allergy Clin Immunol"},{"key":"1640_CR82","first-page":"344","volume":"90","author":"RR Gifford","year":"1981","unstructured":"Gifford RR, Voss BV, Ferguson RM (1981) Cimetidine protection against lethal tumor challenge in mice. Surgery 90:344\u2013351","journal-title":"Surgery"},{"key":"1640_CR83","first-page":"184","volume":"103","author":"RR Gifford","year":"1988","unstructured":"Gifford RR, Voss BV, Schmidtke JR, Ferguson RM (1988) Histamine type-2 receptor antagonist immune modulation. I. Increased cell-mediated cytotoxicity in normal and in down-regulated systems. Surgery 103:184\u2013192","journal-title":"Surgery"},{"key":"1640_CR84","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/s0002-9440(10)61102-9","volume":"160","author":"L Graff","year":"2002","unstructured":"Graff L, Frungieri M, Zanner R, Pohlinger A, Prinz C, Gratzl M (2002) Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma. Am J Pathol 160:1561\u20131565. https:\/\/doi.org\/10.1016\/s0002-9440(10)61102-9","journal-title":"Am J Pathol"},{"key":"1640_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00262-018-2253-6","volume":"68","author":"H Grauers Wiktorin","year":"2019","unstructured":"Grauers Wiktorin H, Nilsson MS, Kiffin R, Sander FE, Lenox B, Rydstr\u00f6m A, Hellstrand K, Martner A (2019) Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1\/PD-L1 checkpoint blockade. Cancer Immunol Immunother 68:163\u2013174. https:\/\/doi.org\/10.1007\/s00262-018-2253-6","journal-title":"Cancer Immunol Immunother"},{"key":"1640_CR86","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jhep.2019.11.007","volume":"72","author":"Y Guan","year":"2020","unstructured":"Guan Y, Chen X, Wu M, Zhu W, Arslan A, Takeda S, Nguyen MH, Majeti R, Thomas D, Zheng M, Peltz G (2020) The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy. J Hepatol 72:746\u2013760. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.007","journal-title":"J Hepatol"},{"key":"1640_CR87","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","volume":"24","author":"JL Guerriero","year":"2018","unstructured":"Guerriero JL (2018) Macrophages: the road less traveled, changing anticancer therapy. Trends Mol Med 24:472\u2013489. https:\/\/doi.org\/10.1016\/j.molmed.2018.03.006","journal-title":"Trends Mol Med"},{"key":"1640_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012360","volume":"5","author":"M Gulliksson","year":"2010","unstructured":"Gulliksson M, Carvalho RF, Uller\u00e5s E, Nilsson G (2010) Mast cell survival and mediator secretion in response to hypoxia. PLoS ONE 5:e12360. https:\/\/doi.org\/10.1371\/journal.pone.0012360","journal-title":"PLoS ONE"},{"key":"1640_CR89","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/10781552241247007","volume":"30","author":"W Gunasekara","year":"2024","unstructured":"Gunasekara W, Sachindra J, Madhushika MT, Liyanage P, Lekamwasam S (2024) Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: a systematic review. J Oncol Pharm Pract 30:930\u2013936. https:\/\/doi.org\/10.1177\/10781552241247007","journal-title":"J Oncol Pharm Pract"},{"key":"1640_CR90","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.exphem.2010.05.008","volume":"38","author":"E Hadzijusufovic","year":"2010","unstructured":"Hadzijusufovic E, Peter B, Gleixner KV, Schuch K, Pickl WF, Thaiwong T, Yuzbasiyan-Gurkan V, Mirkina I, Willmann M, Valent P (2010) H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Exp Hematol 38:896\u2013907. https:\/\/doi.org\/10.1016\/j.exphem.2010.05.008","journal-title":"Exp Hematol"},{"key":"1640_CR91","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0192-0561(96)00044-6","volume":"18","author":"KB Hahm","year":"1996","unstructured":"Hahm KB, Park IS, Kim HC, Lee KJ, Kim JH, Cho SW, Lee SI (1996) Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. Int J Immunopharmacol 18:393\u2013399. https:\/\/doi.org\/10.1016\/s0192-0561(96)00044-6","journal-title":"Int J Immunopharmacol"},{"key":"1640_CR92","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1080\/03007995.2024.2427323","volume":"40","author":"O Hamid","year":"2024","unstructured":"Hamid O, Hamidi N (2024) Enhancing immuno-oncology efficacy with H1-antihistamine in cancer therapy: a review of current research and findings. Curr Med Res Opin 40:2139\u20132146. https:\/\/doi.org\/10.1080\/03007995.2024.2427323","journal-title":"Curr Med Res Opin"},{"key":"1640_CR93","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jphs.2023.02.006","volume":"151","author":"OF Hatipoglu","year":"2023","unstructured":"Hatipoglu OF, Nishinaka T, Nishibori M, Watanabe M, Toyomura T, Mori S, Yaykasli KO, Wake H, Takahashi H (2023) Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. J Pharmacol Sci 151:177\u2013186. https:\/\/doi.org\/10.1016\/j.jphs.2023.02.006","journal-title":"J Pharmacol Sci"},{"key":"1640_CR94","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.gene.2013.02.020","volume":"519","author":"GH He","year":"2013","unstructured":"He GH, Lu J, Shi PP, Xia W, Yin SJ, Jin TB, Chen DD, Xu GL (2013) Polymorphisms of human histamine receptor H4 gene are associated with breast cancer in Chinese Han population. Gene 519:260\u2013265. https:\/\/doi.org\/10.1016\/j.gene.2013.02.020","journal-title":"Gene"},{"key":"1640_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12032-020-01452-z","volume":"38","author":"SK Hegazy","year":"2021","unstructured":"Hegazy SK, El-Haggar SM, Alhassanin SA, El-Berri EI (2021) Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma. Med Oncol 38:4. https:\/\/doi.org\/10.1007\/s12032-020-01452-z","journal-title":"Med Oncol"},{"key":"1640_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.0022-202x.2001.01406.x","volume":"117","author":"H Hegyesi","year":"2001","unstructured":"Hegyesi H, Somlai B, Varga VL, Toth G, Kovacs P, Molnar EL, Laszlo V, Karpati S, Rivera E, Falus A, Darvas Z (2001) Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol 117:151\u2013153. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01406.x","journal-title":"J Invest Dermatol"},{"key":"1640_CR97","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.febslet.2005.03.053","volume":"579","author":"H Hegyesi","year":"2005","unstructured":"Hegyesi H, Horv\u00e1th B, P\u00e1llinger \u00c9, P\u00f3s Z, Moln\u00e1r V, Falus A (2005) Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. FEBS Lett 579:2475\u20132479. https:\/\/doi.org\/10.1016\/j.febslet.2005.03.053","journal-title":"FEBS Lett"},{"key":"1640_CR98","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1254\/jphs.fp0070636","volume":"105","author":"H Hegyesi","year":"2007","unstructured":"Hegyesi H, Colombo L, P\u00e1llinger E, T\u00f3th S, Boer K, Moln\u00e1r V, Falus A (2007) Impact of systemic histamine deficiency on the crosstalk between mammary adenocarcinoma and T cells. J Pharmacol Sci 105:66\u201373. https:\/\/doi.org\/10.1254\/jphs.fp0070636","journal-title":"J Pharmacol Sci"},{"key":"1640_CR99","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/pros.23280","volume":"77","author":"HA Hempel","year":"2017","unstructured":"Hempel HA, Cuka NS, Kulac I, Barber JR, Cornish TC, Platz EA, De Marzo AM, Sfanos KS (2017) Low intratumoral mast cells are associated with a higher risk of prostate cancer recurrence. Prostate 77:412\u2013424. https:\/\/doi.org\/10.1002\/pros.23280","journal-title":"Prostate"},{"key":"1640_CR100","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/a:1013338515229","volume":"55","author":"A Hern\u00e1ndez-Angeles","year":"2001","unstructured":"Hern\u00e1ndez-Angeles A, Soria-Jasso LE, Ortega A, Arias-Monta\u00f1o JA (2001) Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells. J Neurooncol 55:81\u201389. https:\/\/doi.org\/10.1023\/a:1013338515229","journal-title":"J Neurooncol"},{"key":"1640_CR101","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/clpt.1992.135","volume":"52","author":"PK Honig","year":"1992","unstructured":"Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. (1992) Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52:231\u2013238. https:\/\/doi.org\/10.1038\/clpt.1992.135","journal-title":"Clin Pharmacol Ther"},{"key":"1640_CR102","first-page":"1513","volume":"269","author":"PK Honig","year":"1993","unstructured":"Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR (1993) Terfenadine-ketoconazole interaction. Pharmacokinetic and Electrocardiographic Consequences Jama 269:1513\u20131518","journal-title":"Pharmacokinetic and Electrocardiographic Consequences Jama"},{"key":"1640_CR103","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061. https:\/\/doi.org\/10.1126\/science.1079490","journal-title":"Science"},{"key":"1640_CR104","first-page":"584","volume":"7","author":"MC Hsieh","year":"2017","unstructured":"Hsieh MC, Lee WH, Wu AT, Chow JM, Chang CL, Yuan KS, Wu SY (2017) Cyproheptadine use in hepatocellular carcinoma. Am J Cancer Res 7:584\u2013602","journal-title":"Am J Cancer Res"},{"key":"1640_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40360-021-00533-7","volume":"22","author":"J Huang","year":"2021","unstructured":"Huang J, Fan P, Liu M, Weng C, Fan G, Zhang T, Duan X, Wu Y, Tang L, Yang G, Liu Y (2021) Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells. BMC Pharmacol Toxicol 22:62. https:\/\/doi.org\/10.1186\/s40360-021-00533-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"1640_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1068443","volume":"12","author":"W Huang","year":"2022","unstructured":"Huang W, Yang S, Cheng YS, Sima N, Sun W, Shen M, Braisted JC, Lu W, Zheng W (2022) Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII\/CREB1 mediated ABCB1 expression. Front Oncol 12:1068443. https:\/\/doi.org\/10.3389\/fonc.2022.1068443","journal-title":"Front Oncol"},{"key":"1640_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15551-6","volume":"12","author":"SSA Ibrahim","year":"2022","unstructured":"Ibrahim SSA, El-Aal SaA., Reda AM, Achy SE, Shahine Y (2022) Anti-neoplastic action of Cimetidine\/Vitamin C on histamine and the PI3K\/AKT\/mTOR pathway in Ehrlich breast cancer. Sci Rep 12:11514. https:\/\/doi.org\/10.1038\/s41598-022-15551-6","journal-title":"Sci Rep"},{"key":"1640_CR108","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/cad.0000000000000670","volume":"29","author":"ID Ionov","year":"2018","unstructured":"Ionov ID, Gorev NP, Roslavtseva LA, Frenkel DD (2018) Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats. Anticancer Drugs 29:956\u2013964. https:\/\/doi.org\/10.1097\/cad.0000000000000670","journal-title":"Anticancer Drugs"},{"key":"1640_CR109","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2019.02.026","volume":"70","author":"A Jafarzadeh","year":"2019","unstructured":"Jafarzadeh A, Nemati M, Khorramdelazad H, Hassan ZM (2019) Immunomodulatory properties of cimetidine: its therapeutic potentials for treatment of immune-related diseases. Int Immunopharmacol 70:156\u2013166. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.026","journal-title":"Int Immunopharmacol"},{"key":"1640_CR110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12272-025-01532-6","volume":"48","author":"JH Jang","year":"2025","unstructured":"Jang JH, Kim DH, Chun KS (2025) Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation. Arch Pharm Res 48:115\u2013131. https:\/\/doi.org\/10.1007\/s12272-025-01532-6","journal-title":"Arch Pharm Res"},{"key":"1640_CR111","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3727\/0965040041292369","volume":"14","author":"SM Jangi","year":"2004","unstructured":"Jangi SM, Asumendi A, Arlucea J, Nieto N, Perez-Yarza G, Morales MC, De La Fuente-Pinedo M, Boyano MD (2004) Apoptosis of human T-cell acute lymphoblastic leukemia cells by diphenhydramine, an H1 histamine receptor antagonist. Oncol Res 14:363\u2013372. https:\/\/doi.org\/10.3727\/0965040041292369","journal-title":"Oncol Res"},{"key":"1640_CR112","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/carcin\/bgl021","volume":"27","author":"SM Jangi","year":"2006","unstructured":"Jangi SM, D\u00edaz-P\u00e9rez JL, Ochoa-Lizarralde B, Mart\u00edn-Ruiz I, Asumendi A, P\u00e9rez-Yarza G, Gardeazabal J, D\u00edaz-Ram\u00f3n JL, Boyano MD (2006) H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 27:1787\u20131796. https:\/\/doi.org\/10.1093\/carcin\/bgl021","journal-title":"Carcinogenesis"},{"key":"1640_CR113","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/carcin\/bgm292","volume":"29","author":"SM Jangi","year":"2008","unstructured":"Jangi SM, Ruiz-Larrea MB, Nicolau-Galm\u00e9s F, Andollo N, Arroyo-Berdugo Y, Ortega-Mart\u00ednez I, D\u00edaz-P\u00e9rez JL, Boyano MD (2008) Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis 29:500\u2013509. https:\/\/doi.org\/10.1093\/carcin\/bgm292","journal-title":"Carcinogenesis"},{"key":"1640_CR114","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13402-023-00822-9","volume":"46","author":"Y Ji","year":"2023","unstructured":"Ji Y, Liu B, Chen L, Li A, Shen K, Su R, Zhang W, Zhu Y, Wang Q, Xue W (2023) Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6\/STAT3 pathway. Cell Oncol (Dordr) 46:1445\u20131456. https:\/\/doi.org\/10.1007\/s13402-023-00822-9","journal-title":"Cell Oncol (Dordr)"},{"key":"1640_CR115","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/or_00000686","volume":"23","author":"CG Jiang","year":"2010","unstructured":"Jiang CG, Liu FR, Yu M, Li JB, Xu HM (2010) Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo. Oncol Rep 23:693\u2013700. https:\/\/doi.org\/10.3892\/or_00000686","journal-title":"Oncol Rep"},{"key":"1640_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1414884","volume":"15","author":"B Jiang","year":"2024","unstructured":"Jiang B, Wu Z, Zhang Y, Yang X (2024) Associations between tertiary lymphoid structure density and immune checkpoint inhibitor efficacy in solid tumors: systematic review and meta-analysis. Front Immunol 15:1414884. https:\/\/doi.org\/10.3389\/fimmu.2024.1414884","journal-title":"Front Immunol"},{"key":"1640_CR117","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1182\/blood-2024-211896","volume":"144","author":"H Jin","year":"2024","unstructured":"Jin H, Wang L, Ren Y, Wu Z, Shi W, Li J (2024) Role and mechanisms exploration of histamine and its receptors in the progression of peripheral T-cell lymphoma. Blood 144:4378. https:\/\/doi.org\/10.1182\/blood-2024-211896","journal-title":"Blood"},{"key":"1640_CR118","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1674-5","volume":"574","author":"RJ Johnston","year":"2019","unstructured":"Johnston RJ, Su LJ, Pinckney J, Critton D, Boyer E, Krishnakumar A, Corbett M, Rankin AL, Dibella R, Campbell L, Martin GH, Lemar H, Cayton T, Huang RY, Deng X, Nayeem A, Chen H, Ergel B, Rizzo JM, Yamniuk AP, Dutta S, Ngo J, Shorts AO, Ramakrishnan R, Kozhich A, Holloway J, Fang H, Wang YK, Yang Z, Thiam K, Rakestraw G, Rajpal A, Sheppard P, Quigley M, Bahjat KS, Korman AJ (2019) VISTA is an acidic pH-selective ligand for PSGL-1. Nature 574:565\u2013570. https:\/\/doi.org\/10.1038\/s41586-019-1674-5","journal-title":"Nature"},{"key":"1640_CR119","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s43188-024-00259-8","volume":"40","author":"SH Joo","year":"2024","unstructured":"Joo SH, Chun KS (2024) Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists. Toxicol Res 40:533\u2013540. https:\/\/doi.org\/10.1007\/s43188-024-00259-8","journal-title":"Toxicol Res"},{"key":"1640_CR120","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jconrel.2017.11.019","volume":"269","author":"F Joris","year":"2018","unstructured":"Joris F, De Backer L, Van De Vyver T, Bastiancich C, De Smedt SC, Raemdonck K (2018) Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells. J Control Release 269:266\u2013276. https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.019","journal-title":"J Control Release"},{"key":"1640_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26691-0","volume":"12","author":"KI Joung","year":"2022","unstructured":"Joung KI, Hwang JE, Oh IS, Cho SI, Shin JY (2022) Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea. Sci Rep 12:22396. https:\/\/doi.org\/10.1038\/s41598-022-26691-0","journal-title":"Sci Rep"},{"key":"1640_CR122","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/35096564","volume":"413","author":"M Jutel","year":"2001","unstructured":"Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser K, Akdis CA (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420\u2013425. https:\/\/doi.org\/10.1038\/35096564","journal-title":"Nature"},{"key":"1640_CR123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000085108","volume":"137","author":"M Jutel","year":"2005","unstructured":"Jutel M, Blaser K, Akdis CA (2005) Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137:82\u201392. https:\/\/doi.org\/10.1159\/000085108","journal-title":"Int Arch Allergy Immunol"},{"key":"1640_CR124","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1365-2222.2009.03374.x","volume":"39","author":"M Jutel","year":"2009","unstructured":"Jutel M, Akdis M, Akdis CA (2009) Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 39:1786\u20131800. https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03374.x","journal-title":"Clin Exp Allergy"},{"key":"1640_CR125","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00001813-200103000-00012","volume":"12","author":"WM Kan","year":"2001","unstructured":"Kan WM, Liu YT, Hsiao CL, Shieh CY, Kuo JH, Huang JD, Su SF (2001) Effect of hydroxyzine on the transport of etoposide in rat small intestine. Anticancer Drugs 12:267\u2013273. https:\/\/doi.org\/10.1097\/00001813-200103000-00012","journal-title":"Anticancer Drugs"},{"key":"1640_CR126","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1053\/j.gastro.2020.12.037","volume":"160","author":"ED Kantor","year":"2021","unstructured":"Kantor ED, O\u2019connell K, Du M, Mendelsohn RB, Liang PS, Braunstein LZ (2021) Ranitidine use and cancer risk: results from UK Biobank. Gastroenterology 160:1856-1859.e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.037","journal-title":"Gastroenterology"},{"key":"1640_CR127","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jss.2005.02.030","volume":"129","author":"S Kapoor","year":"2005","unstructured":"Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T (2005) Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. J Surg Res 129:172\u2013175. https:\/\/doi.org\/10.1016\/j.jss.2005.02.030","journal-title":"J Surg Res"},{"key":"1640_CR128","first-page":"215","volume":"1","author":"L Kennedy","year":"2012","unstructured":"Kennedy L, Hodges K, Meng F, Alpini G, Francis H (2012) Histamine and histamine receptor regulation of gastrointestinal cancers. Transl Gastrointest Cancer 1:215\u2013227","journal-title":"Transl Gastrointest Cancer"},{"key":"1640_CR129","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/aap.12037","volume":"35","author":"JM Keppel Hesselink","year":"2015","unstructured":"Keppel Hesselink JM (2015) The terms \u2018autacoid\u2019, \u2018hormone\u2019 and \u2018chalone\u2019 and how they have shifted with time. Auton Autacoid Pharmacol 35:51\u201358. https:\/\/doi.org\/10.1111\/aap.12037","journal-title":"Auton Autacoid Pharmacol"},{"key":"1640_CR130","first-page":"495","volume":"74","author":"Y Kikuchi","year":"1985","unstructured":"Kikuchi Y, Oomori K, Kizawa I, Kato K (1985) Effects of cimetidine on tumor growth and immune function in nude mice bearing human ovarian carcinoma. J Natl Cancer Inst 74:495\u2013498","journal-title":"J Natl Cancer Inst"},{"key":"1640_CR131","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4062\/biomolther.2014.081","volume":"22","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Park MK, Kim SY, Lee CH (2014) Novel suppressive effects of ketotifen on migration and invasion of MDA-MB-231 and HT-1080 cancer cells. Biomol Ther (Seoul) 22:540\u2013546. https:\/\/doi.org\/10.4062\/biomolther.2014.081","journal-title":"Biomol Ther (Seoul)"},{"key":"1640_CR132","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.21873\/anticanres.13525","volume":"39","author":"JY Kim","year":"2019","unstructured":"Kim JY, Kim KS, Kim IS, Yoon S (2019) Histamine receptor antagonists, loratadine and azelastine, sensitize P-gp-overexpressing antimitotic drug-resistant KBV20C cells through different molecular mechanisms. Anticancer Res 39:3767\u20133775. https:\/\/doi.org\/10.21873\/anticanres.13525","journal-title":"Anticancer Res"},{"key":"1640_CR133","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5114\/aoms.2012.27295","volume":"8","author":"T Kmiecik","year":"2012","unstructured":"Kmiecik T, Otocka-Kmiecik A, G\u00f3rska-Ciebiada M, Ciebiada M (2012) T lymphocytes as a target of histamine action. Arch Med Sci 8:154\u2013161. https:\/\/doi.org\/10.5114\/aoms.2012.27295","journal-title":"Arch Med Sci"},{"key":"1640_CR134","first-page":"3978","volume":"60","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60:3978\u20133984","journal-title":"Cancer Res"},{"key":"1640_CR135","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/106002809002400316","volume":"24","author":"A Kumar","year":"1990","unstructured":"Kumar A (1990) Cimetidine: an immunomodulator. DICP 24:289\u2013295. https:\/\/doi.org\/10.1177\/106002809002400316","journal-title":"DICP"},{"key":"1640_CR136","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s10620-021-06972-w","volume":"67","author":"S Kumar","year":"2022","unstructured":"Kumar S, Goldberg DS, Kaplan DE (2022) Ranitidine use and gastric cancer among persons with Helicobacter pylori. Dig Dis Sci 67:1822\u20131830. https:\/\/doi.org\/10.1007\/s10620-021-06972-w","journal-title":"Dig Dis Sci"},{"key":"1640_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28062556","author":"X Lai","year":"2023","unstructured":"Lai X, Yao F, An Y, Li X, Yang XD (2023) Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles. Molecules. https:\/\/doi.org\/10.3390\/molecules28062556","journal-title":"Molecules"},{"key":"1640_CR138","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/sj.bjc.6690457","volume":"81","author":"MJ Langman","year":"1999","unstructured":"Langman MJ, Dunn JA, Whiting JL, Burton A, Hallissey MT, Fielding JW, Kerr DJ (1999) Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group. Br J Cancer 81:1356\u20131362. https:\/\/doi.org\/10.1038\/sj.bjc.6690457","journal-title":"Br J Cancer"},{"key":"1640_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-025-02054-z","volume":"74","author":"P Lauretta","year":"2025","unstructured":"Lauretta P, Martinez Vivot R, Velazco A, Medina VA (2025) Histamine H3 receptor: an emerging target for cancer therapy? Inflamm Res 74:97. https:\/\/doi.org\/10.1007\/s00011-025-02054-z","journal-title":"Inflamm Res"},{"key":"1640_CR140","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000341637","volume":"160","author":"CL Lee","year":"2013","unstructured":"Lee CL, Hsu SH, Jong YJ, Hung CH, Suen JL (2013) Inhibition of histamine H1 receptor activity modulates proinflammatory cytokine production of dendritic cells through c-Rel activity. Int Arch Allergy Immunol 160:265\u2013274. https:\/\/doi.org\/10.1159\/000341637","journal-title":"Int Arch Allergy Immunol"},{"key":"1640_CR141","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fcell.2020.00672","volume":"8","author":"Q Lei","year":"2020","unstructured":"Lei Q, Wang D, Sun K, Wang L, Zhang Y (2020a) Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors. Front Cell Dev Biol 8:672. https:\/\/doi.org\/10.3389\/fcell.2020.00672","journal-title":"Front Cell Dev Biol"},{"key":"1640_CR142","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB (2020b) Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett 470:126\u2013133. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.009","journal-title":"Cancer Lett"},{"key":"1640_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70583","volume":"14","author":"Y Leung","year":"2025","unstructured":"Leung Y, Yip TC, Wong GL, Wong VW, Hui VW, Mok TS, Chan HL, Chan SL, Lui RN (2025) Concomitant usage of H1-antihistamines and immune checkpoint inhibitors on cancer patient survival. Cancer Med 14:e70583. https:\/\/doi.org\/10.1002\/cam4.70583","journal-title":"Cancer Med"},{"key":"1640_CR144","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","volume":"32","author":"R Leurs","year":"2002","unstructured":"Leurs R, Church MK, Taglialatela M (2002) H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32:489\u2013498. https:\/\/doi.org\/10.1046\/j.0954-7894.2002.01314.x","journal-title":"Clin Exp Allergy"},{"key":"1640_CR145","first-page":"504","volume":"52","author":"Y Li","year":"2005","unstructured":"Li Y, Yang GL, Yuan HY, Bai DJ, Wang K, Lin CR, Hu MB, Feng MH (2005) Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial. Hepatogastroenterology 52:504\u2013508","journal-title":"Hepatogastroenterology"},{"key":"1640_CR146","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5754\/hge12573","volume":"60","author":"B Li","year":"2013","unstructured":"Li B, Cao F, Zhu Q, Li B, Gan M, Wang D (2013) Perioperative cimetidine administration improves systematic immune response and tumor infiltrating lymphocytes in patients with colorectal cancer. Hepatogastroenterology 60:244\u2013247. https:\/\/doi.org\/10.5754\/hge12573","journal-title":"Hepatogastroenterology"},{"key":"1640_CR147","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1535-7163.Mct-20-0250","volume":"19","author":"Q Li","year":"2020","unstructured":"Li Q, Liu KY, Liu Q, Wang G, Jiang W, Meng Q, Yi Y, Yang Y, Wang R, Zhu S, Li C, Wu L, Zhao D, Yan L, Zhang L, Kim JS, Zu X, Kozielski AJ, Qian W, Chang JC, Patnaik A, Chen K, Cao Q (2020) Antihistamine drug ebastine inhibits cancer growth by targeting polycomb group protein EZH2. Mol Cancer Ther 19:2023\u20132033. https:\/\/doi.org\/10.1158\/1535-7163.Mct-20-0250","journal-title":"Mol Cancer Ther"},{"key":"1640_CR148","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","volume":"40","author":"H Li","year":"2022","unstructured":"Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, Yin X, Saito Y, Fan H, Li P, Kuo WL, Halpin A, Gibbons DL, Yagita H, Zhao Z, Pang D, Ren G, Yee C, Lee JJ, Yu D (2022) The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell 40:36-52.e9. https:\/\/doi.org\/10.1016\/j.ccell.2021.11.002","journal-title":"Cancer Cell"},{"key":"1640_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061610","author":"YC Liang","year":"2020","unstructured":"Liang YC, Chang CC, Sheu MT, Lin SY, Chung CC, Teng CT, Suk FM (2020) The antihistamine deptropine induces hepatoma cell death through blocking autophagosome-lysosome fusion. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12061610","journal-title":"Cancers (Basel)"},{"key":"1640_CR150","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0008-8749(81)90484-6","volume":"64","author":"M Lima","year":"1981","unstructured":"Lima M, Rocklin RE (1981) Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cells. Cell Immunol 64:324\u2013336. https:\/\/doi.org\/10.1016\/0008-8749(81)90484-6","journal-title":"Cell Immunol"},{"key":"1640_CR151","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3748\/wjg.v10.i1.136","volume":"10","author":"CY Lin","year":"2004","unstructured":"Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y (2004) Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial. World J Gastroenterol 10:136\u2013142. https:\/\/doi.org\/10.3748\/wjg.v10.i1.136","journal-title":"World J Gastroenterol"},{"key":"1640_CR152","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.fct.2006.11.016","volume":"45","author":"JC Lin","year":"2007","unstructured":"Lin JC, Ho YS, Lee JJ, Liu CL, Yang TL, Wu CH (2007) Induction of apoptosis and cell-cycle arrest in human colon cancer cells by meclizine. Food Chem Toxicol 45:935\u2013944. https:\/\/doi.org\/10.1016\/j.fct.2006.11.016","journal-title":"Food Chem Toxicol"},{"key":"1640_CR153","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3672","author":"JJ Lin","year":"2015","unstructured":"Lin JJ, Zhao TZ, Cai WK, Yang YX, Sun C, Zhang Z, Xu YQ, Chang T, Li ZY (2015) Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion and epithelial-to-mesenchymal transition. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.3672","journal-title":"Oncotarget"},{"key":"1640_CR154","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/cad.0000000000000972","volume":"31","author":"X Lin","year":"2020","unstructured":"Lin X, Zhang J, Wang X, Lin G, Chen T (2020) Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer. Anticancer Drugs 31:989\u2013996. https:\/\/doi.org\/10.1097\/cad.0000000000000972","journal-title":"Anticancer Drugs"},{"key":"1640_CR155","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/s0748-7983(95)97083-5","volume":"21","author":"M Links","year":"1995","unstructured":"Links M, Clingan PR, Phadke K, O\u2019baugh J, Legge J, Adams WJ, Ross WB, Morris DL (1995) A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer. Eur J Surg Oncol 21:523\u2013525. https:\/\/doi.org\/10.1016\/s0748-7983(95)97083-5","journal-title":"Eur J Surg Oncol"},{"key":"1640_CR156","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.anai.2023.07.019","volume":"131","author":"S Linton","year":"2023","unstructured":"Linton S, Hossenbaccus L, Ellis AK (2023) Evidence-based use of antihistamines for treatment of allergic conditions. Ann Allergy Asthma Immunol 131:412\u2013420. https:\/\/doi.org\/10.1016\/j.anai.2023.07.019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1640_CR157","doi-asserted-by":"publisher","first-page":"112128","DOI":"10.1016\/j.intimp.2024.112128","volume":"133","author":"BK Lippi","year":"2024","unstructured":"Lippi BK, Fernandes GA, Azevedo GA, Negreiros NG, Soares AW, Landgraf MA, Fernandes JPS, Landgraf RG (2024) The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice. Int Immunopharmacol 133:112128. https:\/\/doi.org\/10.1016\/j.intimp.2024.112128","journal-title":"Int Immunopharmacol"},{"key":"1640_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112137","volume":"42","author":"B Liu","year":"2023","unstructured":"Liu B, Chen R, Zhang Y, Huang J, Luo Y, Rosth\u00f8j S, Zhao C, J\u00e4\u00e4ttel\u00e4 M (2023a) Cationic amphiphilic antihistamines inhibit STAT3 via Ca2+-dependent lysosomal H+ efflux. Cell Rep 42:112137. https:\/\/doi.org\/10.1016\/j.celrep.2023.112137","journal-title":"Cell Rep"},{"key":"1640_CR159","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2023.2242211","volume":"12","author":"P Liu","year":"2023","unstructured":"Liu P, Kroemer G, Kepp O (2023b) Histamine antagonists promote cancer immunosurveillance. Oncoimmunology 12:2242211. https:\/\/doi.org\/10.1080\/2162402x.2023.2242211","journal-title":"Oncoimmunology"},{"key":"1640_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02914-8","volume":"43","author":"X Liu","year":"2024","unstructured":"Liu X, Zhong R, Huang J, Chen Z, Xu H, Lin L, Cai Q, He M, Lao S, Deng H, Li C, Li J, Zheng Y, Liu X, Zeng R, He J, Liang W (2024) Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer. J Exp Clin Cancer Res 43:5. https:\/\/doi.org\/10.1186\/s13046-023-02914-8","journal-title":"J Exp Clin Cancer Res"},{"key":"1640_CR161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1871520616666160321115349","volume":"18","author":"G Losurdo","year":"2018","unstructured":"Losurdo G, Principi M, Girardi B, Pricci M, Barone M, Ierardi E, Di Leo A (2018) Histamine and histaminergic receptors in colorectal cancer: from basic science to evidence-based medicine. Anticancer Agents Med Chem 18:15\u201320. https:\/\/doi.org\/10.2174\/1871520616666160321115349","journal-title":"Anticancer Agents Med Chem"},{"key":"1640_CR162","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jcb.24440","volume":"114","author":"Q Lu","year":"2013","unstructured":"Lu Q, Wang C, Pan R, Gao X, Wei Z, Xia Y, Dai Y (2013) Histamine synergistically promotes bFGF-induced angiogenesis by enhancing VEGF production via H1 receptor. J Cell Biochem 114:1009\u20131019. https:\/\/doi.org\/10.1002\/jcb.24440","journal-title":"J Cell Biochem"},{"key":"1640_CR163","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/s41401-024-01301-z","volume":"45","author":"J Lu","year":"2024","unstructured":"Lu J, Zhao XJ, Ruan Y, Liu XJ, Di X, Xu R, Wang JY, Qian MY, Jin HM, Li WJ, Shen X (2024) Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice. Acta Pharmacol Sin 45:2061\u20132076. https:\/\/doi.org\/10.1038\/s41401-024-01301-z","journal-title":"Acta Pharmacol Sin"},{"key":"1640_CR164","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820926591","volume":"19","author":"J Ma","year":"2020","unstructured":"Ma J, Qi J, Li S, Zhang C, Wang H, Shao L, Yuan X, Sha Q (2020) Desloratadine, a novel antigrowth reagent for bladder cancer. Technol Cancer Res Treat 19:1533033820926591. https:\/\/doi.org\/10.1177\/1533033820926591","journal-title":"Technol Cancer Res Treat"},{"key":"1640_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03643-w","volume":"20","author":"D Mallardo","year":"2022","unstructured":"Mallardo D, Simeone E, Vanella V, Vitale MG, Palla M, Scarpato L, Paone M, De Cristofaro T, Borzillo V, Cortellini A, Sparano F, Pignata S, Fiore F, Carac\u00f2 C, Maiolino P, Petrillo A, Cavalcanti E, Lastoria S, Muto P, Budillon A, Warren S, Ascierto PA (2022) Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization. J Transl Med 20:436. https:\/\/doi.org\/10.1186\/s12967-022-03643-w","journal-title":"J Transl Med"},{"key":"1640_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212439","author":"D Mallardo","year":"2024","unstructured":"Mallardo D, Fordellone M, Ottaviano M, Marano G, Vitale MG, Mallardo M, Capasso M, De Cristofaro T, Capone M, Meinardi T, Paone M, Sabatelli P, De Filippi R, Cesano A, Cavalcanti E, Carac\u00f2 C, Warren S, Budillon A, Simeone E, Ascierto PA (2024) ICOSLG is associated with anti-PD-1 and concomitant antihistamine treatment response in advanced melanoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252212439","journal-title":"Int J Mol Sci"},{"key":"1640_CR167","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20:131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1","journal-title":"Mol Cancer"},{"key":"1640_CR168","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00004714-199712000-00003","volume":"17","author":"DE Martin","year":"1997","unstructured":"Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK (1997) Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol 17:451\u2013459. https:\/\/doi.org\/10.1097\/00004714-199712000-00003","journal-title":"J Clin Psychopharmacol"},{"key":"1640_CR169","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bph.12137","volume":"170","author":"DJ Martinel Lamas","year":"2013","unstructured":"Martinel Lamas DJ, Croci M, Carabajal E, Crescenti EJ, Sambuco L, Massari NA, Bergoc RM, Rivera ES, Medina VA (2013) Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model. Br J Pharmacol 170:188\u2013199. https:\/\/doi.org\/10.1111\/bph.12137","journal-title":"Br J Pharmacol"},{"issue":"13","key":"1640_CR170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12703\/p6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6(13):7. https:\/\/doi.org\/10.12703\/p6-13","journal-title":"F1000Prime Rep"},{"key":"1640_CR171","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jdermsci.2013.07.012","volume":"72","author":"NA Massari","year":"2013","unstructured":"Massari NA, Medina VA, Cricco GP, Martinel Lamas DJ, Sambuco L, Pagotto R, Ventura C, Ciraolo PJ, Pignataro O, Bergoc RM, Rivera ES (2013) Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma. J Dermatol Sci 72:252\u2013262. https:\/\/doi.org\/10.1016\/j.jdermsci.2013.07.012","journal-title":"J Dermatol Sci"},{"key":"1640_CR172","doi-asserted-by":"publisher","first-page":"26471","DOI":"10.18632\/oncotarget.15594","volume":"8","author":"NA Massari","year":"2017","unstructured":"Massari NA, Nicoud MB, Sambuco L, Cricco GP, Martinel Lamas DJ, Herrero Ducloux MV, Blanco H, Rivera ES, Medina VA (2017) Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation. Oncotarget 8:26471\u201326491. https:\/\/doi.org\/10.18632\/oncotarget.15594","journal-title":"Oncotarget"},{"key":"1640_CR173","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bph.14535","volume":"177","author":"NA Massari","year":"2020","unstructured":"Massari NA, Nicoud MB, Medina VA (2020) Histamine receptors and cancer pharmacology: an update. Br J Pharmacol 177:516\u2013538. https:\/\/doi.org\/10.1111\/bph.14535","journal-title":"Br J Pharmacol"},{"key":"1640_CR174","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bjc.6600048","volume":"86","author":"S Matsumoto","year":"2002","unstructured":"Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T (2002) Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86:161\u2013167. https:\/\/doi.org\/10.1038\/sj.bjc.6600048","journal-title":"Br J Cancer"},{"key":"1640_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81077-y","volume":"11","author":"N Matsumoto","year":"2021","unstructured":"Matsumoto N, Ebihara M, Oishi S, Fujimoto Y, Okada T, Imamura T (2021) Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells. Sci Rep 11:1492. https:\/\/doi.org\/10.1038\/s41598-021-81077-y","journal-title":"Sci Rep"},{"key":"1640_CR176","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4161\/cbt.5.11.3273","volume":"5","author":"V Medina","year":"2006","unstructured":"Medina V, Cricco G, Nu\u00f1ez M, Mart\u00edn G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R, Rivera ES (2006) Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther 5:1462\u20131471. https:\/\/doi.org\/10.4161\/cbt.5.11.3273","journal-title":"Cancer Biol Ther"},{"key":"1640_CR177","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/cbt.7.1.5123","volume":"7","author":"V Medina","year":"2008","unstructured":"Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jim\u00e9nez F, Massari N, Nu\u00f1ez M, Cricco G, Martin G, Bergoc R, Rivera E (2008) The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther 7:28\u201335. https:\/\/doi.org\/10.4161\/cbt.7.1.5123","journal-title":"Cancer Biol Ther"},{"key":"1640_CR178","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/1878-0261.12648","volume":"14","author":"M Melnikova","year":"2020","unstructured":"Melnikova M, Wauer US, Mendus D, Hilger RA, Oliver TG, Mercer K, Gohlke BO, Erdmann K, Niederacher D, Neubauer H, Buderath P, Wimberger P, Kuhlmann JD, Thomale J (2020) Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Mol Oncol 14:686\u2013703. https:\/\/doi.org\/10.1002\/1878-0261.12648","journal-title":"Mol Oncol"},{"key":"1640_CR179","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.24573","volume":"54","author":"F Meng","year":"2011","unstructured":"Meng F, Han Y, Staloch D, Francis T, Stokes A, Francis H (2011) The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Hepatology 54:1718\u20131728. https:\/\/doi.org\/10.1002\/hep.24573","journal-title":"Hepatology"},{"key":"1640_CR180","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/s1471-4906(02)00009-1","volume":"24","author":"S Mocellin","year":"2003","unstructured":"Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM (2003) The dual role of IL-10. Trends Immunol 24:36\u201343. https:\/\/doi.org\/10.1016\/s1471-4906(02)00009-1","journal-title":"Trends Immunol"},{"key":"1640_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116164","volume":"223","author":"NA Mohamad","year":"2024","unstructured":"Mohamad NA, Galarza TE, Mart\u00edn GA (2024) H2 antihistamines: may be useful for combination therapies in cancer? Biochem Pharmacol 223:116164. https:\/\/doi.org\/10.1016\/j.bcp.2024.116164","journal-title":"Biochem Pharmacol"},{"key":"1640_CR182","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/odi.12346","volume":"21","author":"A Monti Hughes","year":"2015","unstructured":"Monti Hughes A, Pozzi E, Thorp SI, Curotto P, Medina VA, Martinel Lamas DJ, Rivera ES, Garabalino MA, Far\u00edas RO, Gonzalez SJ, Heber EM, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE (2015) Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model. Oral Dis 21:770\u2013777. https:\/\/doi.org\/10.1111\/odi.12346","journal-title":"Oral Dis"},{"key":"1640_CR183","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/bf00398182","volume":"114","author":"CM Moriarty","year":"1988","unstructured":"Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR (1988) Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 114:588\u2013592. https:\/\/doi.org\/10.1007\/bf00398182","journal-title":"J Cancer Res Clin Oncol"},{"key":"1640_CR184","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/nm1295-1243","volume":"1","author":"DL Morris","year":"1995","unstructured":"Morris DL, Adams WJ (1995) Cimetidine and colorectal cancer-old drug, new use? Nat Med 1:1243\u20131244. https:\/\/doi.org\/10.1038\/nm1295-1243","journal-title":"Nat Med"},{"key":"1640_CR185","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/09553009314551291","volume":"64","author":"H Mozdarani","year":"1993","unstructured":"Mozdarani H, Gharbali A (1993) Radioprotective effects of cimetidine in mouse bone marrow cells exposed to gamma-rays as assayed by the micronucleus test. Int J Radiat Biol 64:189\u2013194. https:\/\/doi.org\/10.1080\/09553009314551291","journal-title":"Int J Radiat Biol"},{"key":"1640_CR186","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mrgentox.2007.08.003","volume":"649","author":"H Mozdarani","year":"2008","unstructured":"Mozdarani H, Ghoraeian P (2008) Modulation of gamma-ray-induced apoptosis in human peripheral blood leukocytes by famotidine and vitamin C. Mutat Res 649:71\u201378. https:\/\/doi.org\/10.1016\/j.mrgentox.2007.08.003","journal-title":"Mutat Res"},{"key":"1640_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123348","volume":"644","author":"C Muntean","year":"2023","unstructured":"Muntean C, Blondeel E, Harinck L, Pednekar K, Prakash J, De Wever O, Chain JL, De Smedt SC, Remaut K, Raemdonck K (2023) Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer. Int J Pharm 644:123348. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123348","journal-title":"Int J Pharm"},{"key":"1640_CR188","first-page":"117","volume":"7","author":"A Naeeji","year":"2017","unstructured":"Naeeji A, Mozdarani H, Shabestani Monfared A, Faeghi F, Ahmadi AA, Gholami M, Behzadi R, Momtaz MR (2017) Oral administration of vitamin C, cimetidine and famotidine on micronuclei induced by low dose radiation in mouse bone marrow cells. J Biomed Phys Eng 7:117\u2013126","journal-title":"J Biomed Phys Eng"},{"key":"1640_CR189","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79421","volume":"17","author":"S Nagy","year":"2025","unstructured":"Nagy S, Denis O, Hussein A, Kesselman MM (2025) The impact of antihistamines on immunotherapy: a systematic review. Cureus 17:e79421. https:\/\/doi.org\/10.7759\/cureus.79421","journal-title":"Cureus"},{"key":"1640_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081232","author":"PL Nguyen","year":"2021","unstructured":"Nguyen PL, Cho J (2021) Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets. Biomolecules. https:\/\/doi.org\/10.3390\/biom11081232","journal-title":"Biomolecules"},{"key":"1640_CR191","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10495-011-0640-y","volume":"16","author":"F Nicolau-Galm\u00e9s","year":"2011","unstructured":"Nicolau-Galm\u00e9s F, Asumendi A, Alonso-Tejerina E, P\u00e9rez-Yarza G, Jangi SM, Gardeazabal J, Arroyo-Berdugo Y, Careaga JM, D\u00edaz-Ram\u00f3n JL, Apraiz A, Boyano MD (2011) Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. Apoptosis 16:1253\u20131267. https:\/\/doi.org\/10.1007\/s10495-011-0640-y","journal-title":"Apoptosis"},{"key":"1640_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00556","volume":"10","author":"MB Nicoud","year":"2019","unstructured":"Nicoud MB, Formoso K, Medina VA (2019) Pathophysiological role of histamine H4 receptor in cancer: therapeutic implications. Front Pharmacol 10:556. https:\/\/doi.org\/10.3389\/fphar.2019.00556","journal-title":"Front Pharmacol"},{"key":"1640_CR193","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00262-020-02672-y","volume":"70","author":"MB Nicoud","year":"2021","unstructured":"Nicoud MB, T\u00e1quez Delgado MA, Sarasola MP, Vidal A, Speisky D, Cremaschi GA, Sterle HA, Medina VA (2021) Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model. Cancer Immunol Immunother 70:233\u2013244. https:\/\/doi.org\/10.1007\/s00262-020-02672-y","journal-title":"Cancer Immunol Immunother"},{"key":"1640_CR194","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/s0748-7983(95)97120-3","volume":"21","author":"HJ Nielsen","year":"1995","unstructured":"Nielsen HJ, Moesgaard F, Hammer JH (1995) Effect of ranitidine and low-dose interleukin-2 in vitro on NK-cell activity in peripheral blood from patients with liver metastases from colorectal cancer. Eur J Surg Oncol 21:526\u2013530. https:\/\/doi.org\/10.1016\/s0748-7983(95)97120-3","journal-title":"Eur J Surg Oncol"},{"key":"1640_CR195","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1046\/j.1365-2168.2002.02223.x","volume":"89","author":"HJ Nielsen","year":"2002","unstructured":"Nielsen HJ, Christensen IJ, Moesgaard F, Kehlet H (2002) Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg 89:1416\u20131422. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02223.x","journal-title":"Br J Surg"},{"key":"1640_CR196","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.116.104752","volume":"90","author":"G Nieto-Alamilla","year":"2016","unstructured":"Nieto-Alamilla G, M\u00e1rquez-G\u00f3mez R, Garc\u00eda-G\u00e1lvez AM, Morales-Figueroa GE, Arias-Monta\u00f1o JA (2016) The histamine H3 receptor: structure, pharmacology, and function. Mol Pharmacol 90:649\u2013673. https:\/\/doi.org\/10.1124\/mol.116.104752","journal-title":"Mol Pharmacol"},{"key":"1640_CR197","doi-asserted-by":"publisher","first-page":"204062072513510","DOI":"10.1177\/20406207251351086","volume":"16","author":"MS Nilsson","year":"2025","unstructured":"Nilsson MS, Martner A, Wennstr\u00f6m L, Hansson M, Thor\u00e9n FB, Hellstrand K (2025) Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia. Ther Adv Hematol 16:20406207251351090. https:\/\/doi.org\/10.1177\/20406207251351086","journal-title":"Ther Adv Hematol"},{"key":"1640_CR198","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1055-9965.Epi-21-0737","volume":"31","author":"M N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard M, Andersen IT, Heide-J\u00f8rgensen U, Erichsen R, Rees JR, Karagas MR, S\u00f8rensen HT (2022) Ranitidine and risk of bladder and kidney cancer: a population-based cohort study. Cancer Epidemiol Biomark Prev 31:45\u201350. https:\/\/doi.org\/10.1158\/1055-9965.Epi-21-0737","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1640_CR199","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4419-8056-4_10","volume":"709","author":"S Nuutinen","year":"2010","unstructured":"Nuutinen S, Panula P (2010) Histamine in neurotransmission and brain diseases. Adv Exp Med Biol 709:95\u2013107. https:\/\/doi.org\/10.1007\/978-1-4419-8056-4_10","journal-title":"Adv Exp Med Biol"},{"key":"1640_CR200","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11095-006-9149-4","volume":"24","author":"T Obradovic","year":"2007","unstructured":"Obradovic T, Dobson GG, Shingaki T, Kungu T, Hidalgo IJ (2007) Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein. Pharm Res 24:318\u2013327. https:\/\/doi.org\/10.1007\/s11095-006-9149-4","journal-title":"Pharm Res"},{"key":"1640_CR201","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.31557\/apjcp.2022.23.6.1847","volume":"23","author":"O Oladpour","year":"2022","unstructured":"Oladpour O, Taghipour F, Hassan ZM, Rezayati MT, Nemati M, Taghipour Z, Jafarzadeh A (2022) Cimetidine and ibuprofen modulate T cell responses in a mouse model of breast cancer. Asian Pac J Cancer Prev 23:1847\u20131858. https:\/\/doi.org\/10.31557\/apjcp.2022.23.6.1847","journal-title":"Asian Pac J Cancer Prev"},{"key":"1640_CR202","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.biomaterials.2018.07.062","volume":"182","author":"C Oleaga","year":"2018","unstructured":"Oleaga C, Riu A, Rothemund S, Lavado A, Mcaleer CW, Long CJ, Persaud K, Narasimhan NS, Tran M, Roles J, Carmona-Moran CA, Sasserath T, Elbrecht DH, Kumanchik L, Bridges LR, Martin C, Schnepper MT, Ekman G, Jackson M, Wang YI, Note R, Langer J, Teissier S, Hickman JJ (2018) Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system. Biomaterials 182:176\u2013190. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.07.062","journal-title":"Biomaterials"},{"key":"1640_CR203","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.3892\/or.2016.5201","volume":"36","author":"CR Or","year":"2016","unstructured":"Or CR, Su HL, Lee WC, Yang SY, Ho C, Chang CC (2016) Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3\/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo. Oncol Rep 36:3465\u20133471. https:\/\/doi.org\/10.3892\/or.2016.5201","journal-title":"Oncol Rep"},{"key":"1640_CR204","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/s0140-6736(81)91554-3","volume":"1","author":"ME Osband","year":"1981","unstructured":"Osband ME, Hamilton D, Shen YJ, Cohen E, Shlesinger M, Lavin P, Brown A, Mccaffrey R (1981) Successful tumour immunotherapy with cimetidine in mice. Lancet 1:636\u2013638. https:\/\/doi.org\/10.1016\/s0140-6736(81)91554-3","journal-title":"Lancet"},{"key":"1640_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116527","volume":"174","author":"IA Ospital","year":"2024","unstructured":"Ospital IA, T\u00e1quez Delgado MA, Nicoud MB, Corr\u00eaa MF, Borges Fernandes GA, Andrade IW, Lauretta P, Mart\u00ednez Vivot R, Comba MB, Zanardi MM, Speisky D, Uriburu JL, Fernandes JPS, Medina VA (2024) Therapeutic potential of LINS01 histamine H(3) receptor antagonists as antineoplastic agents for triple negative breast cancer. Biomed Pharmacother 174:116527. https:\/\/doi.org\/10.1016\/j.biopha.2024.116527","journal-title":"Biomed Pharmacother"},{"key":"1640_CR206","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-24-0246","author":"M Panagi","year":"2024","unstructured":"Panagi M, Mpekris F, Voutouri C, Hadjigeorgiou AG, Symeonidou C, Porfyriou E, Michael C, Stylianou A, Martin JD, Cabral H, Constantinidou A, Stylianopoulos T (2024) Stabilizing tumor resident mast cells restores T cell infiltration and sensitizes sarcomas to PD-L1 inhibition. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-0246","journal-title":"Clin Cancer Res"},{"key":"1640_CR207","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL (2015) International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67:601\u2013655. https:\/\/doi.org\/10.1124\/pr.114.010249","journal-title":"Pharmacol Rev"},{"key":"1640_CR208","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pdpdt.2012.05.005","volume":"10","author":"A Parihar","year":"2013","unstructured":"Parihar A, Dube A, Gupta PK (2013) Photodynamic treatment of oral squamous cell carcinoma in hamster cheek pouch model using chlorin p6-histamine conjugate. Photodiagnosis Photodyn Ther 10:79\u201386. https:\/\/doi.org\/10.1016\/j.pdpdt.2012.05.005","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1640_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28531-1","volume":"13","author":"C Park","year":"2023","unstructured":"Park C, Lee JW, Kim K, Seen DS, Jeong JY, Huh WK (2023) Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration. Sci Rep 13:1894. https:\/\/doi.org\/10.1038\/s41598-023-28531-1","journal-title":"Sci Rep"},{"key":"1640_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411849","author":"SU Park","year":"2025","unstructured":"Park SU, Jung GU, Paik EK, Lee JY, Cho DC, Chung HK, Jo HJ, Jung SJ (2025) Azelastine inhibits triple-negative breast cancer cell viability via an ARF1-dependent mechanism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262411849","journal-title":"Int J Mol Sci"},{"key":"1640_CR211","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/028418602760169415","volume":"41","author":"R Parshad","year":"2002","unstructured":"Parshad R, Kapoor S, Gupta SD, Kumar A, Chattopadhyaya TK (2002) Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study. Acta Oncol 41:362\u2013365. https:\/\/doi.org\/10.1080\/028418602760169415","journal-title":"Acta Oncol"},{"key":"1640_CR212","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/IJCA_2005424_185","volume":"42","author":"R Parshad","year":"2005","unstructured":"Parshad R, Hazrah P, Kumar S, Gupta SD, Ray R, Bal S (2005) Effect of preoperative short course famotidine on TILs and survival in breast cancer. Indian J Cancer 42:185\u2013190","journal-title":"Indian J Cancer"},{"issue":"Suppl 1","key":"1640_CR213","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","volume":"147","author":"ME Parsons","year":"2006","unstructured":"Parsons ME, Ganellin CR (2006) Histamine and its receptors. Br J Pharmacol 147(Suppl 1):S127\u2013S135. https:\/\/doi.org\/10.1038\/sj.bjp.0706440","journal-title":"Br J Pharmacol"},{"key":"1640_CR214","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/gut.42.1.17","volume":"42","author":"JN Primrose","year":"1998","unstructured":"Primrose JN, Miller GV, Preston SR, Gokhale J, Ambrose NS, Ward UM, Mills JG, Ehsanullah RS, Darekar B, Yorkshire GI Tumour Group (1998) A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Gut 42:17\u201319. https:\/\/doi.org\/10.1136\/gut.42.1.17","journal-title":"Gut"},{"key":"1640_CR215","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/cbr.2008.0564","volume":"24","author":"WD Quan Jr.","year":"2009","unstructured":"Quan WD Jr., Quan FM (2009) High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer. Cancer Biother Radiopharm 24:181\u2013183. https:\/\/doi.org\/10.1089\/cbr.2008.0564","journal-title":"Cancer Biother Radiopharm"},{"key":"1640_CR216","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/cbr.2006.21.515","volume":"21","author":"WD Quan Jr.","year":"2006","unstructured":"Quan WD Jr., Vinogradov M, Quan FM, Khan N, Liles DK, Walker PR (2006) Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer. Cancer Biother Radiopharm 21:515\u2013519. https:\/\/doi.org\/10.1089\/cbr.2006.21.515","journal-title":"Cancer Biother Radiopharm"},{"key":"1640_CR217","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1023\/b:ddas.0000043377.30075.ac","volume":"49","author":"S Rajendra","year":"2004","unstructured":"Rajendra S, Mulcahy H, Patchett S, Kumar P (2004) The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig Dis Sci 49:1634\u20131640. https:\/\/doi.org\/10.1023\/b:ddas.0000043377.30075.ac","journal-title":"Dig Dis Sci"},{"key":"1640_CR218","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00066-014-0602-8","volume":"190","author":"A Razzaghdoust","year":"2014","unstructured":"Razzaghdoust A, Mozdarani H, Mofid B (2014) Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I\/II randomized placebo-controlled trial. Strahlenther Onkol 190:739\u2013744. https:\/\/doi.org\/10.1007\/s00066-014-0602-8","journal-title":"Strahlenther Onkol"},{"key":"1640_CR219","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/s0748-7983(97)92388-x","volume":"23","author":"JL Reynolds","year":"1997","unstructured":"Reynolds JL, Akhter J, Adams WJ, Morris DL (1997) Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol 23:224\u2013227. https:\/\/doi.org\/10.1016\/s0748-7983(97)92388-x","journal-title":"Eur J Surg Oncol"},{"key":"1640_CR220","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbadis.2010.11.010","volume":"1822","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Crivellato E (2012) Mast cells, angiogenesis, and tumour growth. Biochim Biophys Acta 1822:2\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2010.11.010","journal-title":"Biochim Biophys Acta"},{"key":"1640_CR221","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s0002-9343(89)80151-2","volume":"87","author":"JM Richter","year":"1989","unstructured":"Richter JM, Colditz GA, Huse DM, Delea TE, Oster G (1989) Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy. Am J Med 87:278\u2013284. https:\/\/doi.org\/10.1016\/s0002-9343(89)80151-2","journal-title":"Am J Med"},{"key":"1640_CR222","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12307-014-0152-8","volume":"8","author":"A Rigoni","year":"2015","unstructured":"Rigoni A, Colombo MP, Pucillo C (2015) The role of mast cells in molding the tumor microenvironment. Cancer Microenviron 8:167\u2013176. https:\/\/doi.org\/10.1007\/s12307-014-0152-8","journal-title":"Cancer Microenviron"},{"key":"1640_CR223","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000338994","volume":"159","author":"D Rittmeyer","year":"2012","unstructured":"Rittmeyer D, Lorentz A (2012) Relationship between allergy and cancer: an overview. Int Arch Allergy Immunol 159:216\u2013225. https:\/\/doi.org\/10.1159\/000338994","journal-title":"Int Arch Allergy Immunol"},{"key":"1640_CR224","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0008-8749(80)90255-5","volume":"51","author":"RE Rocklin","year":"1980","unstructured":"Rocklin RE, Breard J, Gupta S, Good RA, Melmon KL (1980) Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). Cell Immunol 51:226\u2013237. https:\/\/doi.org\/10.1016\/0008-8749(80)90255-5","journal-title":"Cell Immunol"},{"key":"1640_CR225","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0008-8749(83)90367-2","volume":"76","author":"RE Rocklin","year":"1983","unstructured":"Rocklin RE, Blidy A, Kamal M (1983) Physiochemical characterization of human histamine-induced suppressor factor. Cell Immunol 76:243\u2013252. https:\/\/doi.org\/10.1016\/0008-8749(83)90367-2","journal-title":"Cell Immunol"},{"key":"1640_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01894","volume":"9","author":"D Rogers","year":"2018","unstructured":"Rogers D, Vila-Leahey A, Pess\u00f4a AC, Oldford S, Marignani PA, Marshall JS (2018) Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response. Front Immunol 9:1894. https:\/\/doi.org\/10.3389\/fimmu.2018.01894","journal-title":"Front Immunol"},{"key":"1640_CR227","first-page":"1511","volume":"19","author":"J Roy","year":"2008","unstructured":"Roy J, Vantol B, Cowley EA, Blay J, Linsdell P (2008) Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7. Oncol Rep 19:1511\u20131516","journal-title":"Oncol Rep"},{"key":"1640_CR228","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","volume":"21","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21:1105\u20131111. https:\/\/doi.org\/10.1093\/intimm\/dxp095","journal-title":"Int Immunol"},{"key":"1640_CR229","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/odi.13411","volume":"27","author":"A Salem","year":"2021","unstructured":"Salem A, Salo T (2021) Nothing to sneeze at: histamine and histamine receptors in oral carcinogenesis. Oral Dis 27:1090\u20131096. https:\/\/doi.org\/10.1111\/odi.13411","journal-title":"Oral Dis"},{"key":"1640_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103573","volume":"392","author":"C Salmer\u00f3n","year":"2025","unstructured":"Salmer\u00f3n C, Tom\u00e1s Bort E, Sriram K, Javadi-Paydar M, Smitham JE, Pham K, Grose RP, Mccormick PJ, Dinardo A, Weitz J, Tiriac H, Lowy AM, Insel PA (2025) Histamine H1 receptor: a potential therapeutic target for pancreatic ductal adenocarcinoma. J Pharmacol Exp Ther 392:103573. https:\/\/doi.org\/10.1016\/j.jpet.2025.103573","journal-title":"J Pharmacol Exp Ther"},{"key":"1640_CR231","doi-asserted-by":"publisher","first-page":"562","DOI":"10.22074\/cellj.2021.7378","volume":"23","author":"E Samei","year":"2021","unstructured":"Samei E, Mozdarani H, Samiei F, Javadi GH (2021) Radioprotective effects of combined melatonin and famotidine treatment on radiation induced apoptosis in peripheral blood leukocytes of breast cancer patients and normal individuals. Cell J 23:562\u2013567. https:\/\/doi.org\/10.22074\/cellj.2021.7378","journal-title":"Cell J"},{"key":"1640_CR232","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T, Lengfelder E, D\u00f6hner H, Burnett AK, Chen SJ, Mathews V, Iland H, Rego E, Kantarjian H, Ad\u00e8s L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, Lo-Coco F (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133:1630\u20131643. https:\/\/doi.org\/10.1182\/blood-2019-01-894980","journal-title":"Blood"},{"key":"1640_CR233","doi-asserted-by":"publisher","first-page":"e00778","DOI":"10.1002\/prp2.778","volume":"9","author":"MP Sarasola","year":"2021","unstructured":"Sarasola MP, T\u00e1quez Delgado MA, Nicoud MB, Medina VA (2021) Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 9:e00778. https:\/\/doi.org\/10.1002\/prp2.778","journal-title":"Pharmacol Res Perspect"},{"key":"1640_CR234","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040912","author":"B Schirmer","year":"2020","unstructured":"Schirmer B, Rother T, Bruesch I, Bleich A, Werlein C, Jonigk D, Seifert R, Neumann D (2020) Genetic deficiency of the histamine H(4)-receptor reduces experimental colorectal carcinogenesis in mice. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040912","journal-title":"Cancers (Basel)"},{"key":"1640_CR235","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/164_2016_12","volume":"241","author":"E Schlicker","year":"2017","unstructured":"Schlicker E, Kathmann M (2017) Role of the histamine H(3) receptor in the central nervous system. Handb Exp Pharmacol 241:277\u2013299. https:\/\/doi.org\/10.1007\/164_2016_12","journal-title":"Handb Exp Pharmacol"},{"key":"1640_CR236","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuropharm.2015.05.004","volume":"106","author":"EH Schneider","year":"2016","unstructured":"Schneider EH, Seifert R (2016) The histamine H4-receptor and the central and peripheral nervous system: a critical analysis of the literature. Neuropharmacology 106:116\u2013128. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.004","journal-title":"Neuropharmacology"},{"key":"1640_CR237","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163\u2013189. https:\/\/doi.org\/10.1189\/jlb.0603252","journal-title":"J Leukoc Biol"},{"key":"1640_CR238","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/mog.0000000000000308","volume":"32","author":"ML Schubert","year":"2016","unstructured":"Schubert ML (2016) Gastric acid secretion. Curr Opin Gastroenterol 32:452\u2013460. https:\/\/doi.org\/10.1097\/mog.0000000000000308","journal-title":"Curr Opin Gastroenterol"},{"key":"1640_CR239","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-3-319-67591-6_14","volume":"64","author":"EJ Seo","year":"2017","unstructured":"Seo EJ, Fischer N, Efferth T (2017) Role of TCTP for cellular differentiation and cancer therapy. Results Probl Cell Differ 64:263\u2013281. https:\/\/doi.org\/10.1007\/978-3-319-67591-6_14","journal-title":"Results Probl Cell Differ"},{"key":"1640_CR240","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00018-023-04760-5","volume":"80","author":"J Seo","year":"2023","unstructured":"Seo J, Park M, Ko D, Kim S, Park JM, Park S, Nam KD, Farrand L, Yang J, Seok C, Jung E, Kim YJ, Kim JY, Seo JH (2023) Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase. Cell Mol Life Sci 80:132. https:\/\/doi.org\/10.1007\/s00018-023-04760-5","journal-title":"Cell Mol Life Sci"},{"key":"1640_CR241","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/bst20170130","volume":"46","author":"A Serrano-Puebla","year":"2018","unstructured":"Serrano-Puebla A, Boya P (2018) Lysosomal membrane permeabilization as a cell death mechanism in cancer cells. Biochem Soc Trans 46:207\u2013215. https:\/\/doi.org\/10.1042\/bst20170130","journal-title":"Biochem Soc Trans"},{"key":"1640_CR242","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4062\/biomolther.2022.121","volume":"30","author":"R Shakya","year":"2022","unstructured":"Shakya R, Park GH, Joo SH, Shim JH, Choi JS (2022) Hydroxyzine induces cell death in triple-negative breast cancer cells via mitochondrial superoxide and modulation of Jak2\/STAT3 signaling. Biomol Ther (Seoul) 30:585\u2013592. https:\/\/doi.org\/10.4062\/biomolther.2022.121","journal-title":"Biomol Ther (Seoul)"},{"key":"1640_CR243","doi-asserted-by":"publisher","first-page":"G205","DOI":"10.1152\/ajpgi.00212.2018","volume":"316","author":"Z Shi","year":"2019","unstructured":"Shi Z, Fultz RS, Engevik MA, Gao C, Hall A, Major A, Mori-Akiyama Y, Versalovic J (2019) Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis. Am J Physiol Gastrointest Liver Physiol 316:G205-g216. https:\/\/doi.org\/10.1152\/ajpgi.00212.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1640_CR244","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/gutjnl-2023-331715","volume":"73","author":"A Shi","year":"2024","unstructured":"Shi A, Liu Z, Fan Z, Li K, Liu X, Tang Y, Hu J, Li X, Shu L, Zhao L, Huang L, Zhang Z, Lv G, Zhang Z, Xu Y (2024) Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut 73:1350. https:\/\/doi.org\/10.1136\/gutjnl-2023-331715","journal-title":"Gut"},{"key":"1640_CR245","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/all.12159","volume":"68","author":"F Siebenhaar","year":"2013","unstructured":"Siebenhaar F, F\u00f6rtsch A, Krause K, Weller K, Metz M, Magerl M, Martus P, Church MK, Maurer M (2013) Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial. Allergy 68:949\u2013952. https:\/\/doi.org\/10.1111\/all.12159","journal-title":"Allergy"},{"key":"1640_CR246","doi-asserted-by":"publisher","unstructured":"Smith J (2023) Emerging research on autacoids: Potential therapeutic applications. Autacoids J. 4:21 https:\/\/doi.org\/10.35841\/jac.4.3.21","DOI":"10.35841\/jac.4.3.21"},{"key":"1640_CR247","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1748-717x-5-8","volume":"5","author":"BP Soule","year":"2010","unstructured":"Soule BP, Simone NL, Degraff WG, Choudhuri R, Cook JA, Mitchell JB (2010) Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol 5:8. https:\/\/doi.org\/10.1186\/1748-717x-5-8","journal-title":"Radiat Oncol"},{"key":"1640_CR248","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.23.661147","author":"A Srivastava","year":"2025","unstructured":"Srivastava A, Bencomo T, Lee C-N, Mah A, Garcia J, Seow LW, Donohue IM, Tan AJ, Nguyen A, Jiang T, Gombar S, Phu L, Dwivedi P, Rose CM, Brown R, Lee CS (2025) Epithelial tumor cells utilize mast cell-derived histamine to regulate perineural invasion. Biorxiv. https:\/\/doi.org\/10.1101\/2025.06.23.661147","journal-title":"Biorxiv"},{"key":"1640_CR249","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41416-018-0173-z","volume":"120","author":"HA Sterle","year":"2019","unstructured":"Sterle HA, Nicoud MB, Massari NA, T\u00e1quez Delgado MA, Herrero Ducloux MV, Cremaschi GA, Medina VA (2019) Immunomodulatory role of histamine H4 receptor in breast cancer. Br J Cancer 120:128\u2013138. https:\/\/doi.org\/10.1038\/s41416-018-0173-z","journal-title":"Br J Cancer"},{"key":"1640_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184619","author":"MA Sun","year":"2023","unstructured":"Sun MA, Yang R, Liu H, Wang W, Song X, Hu B, Reynolds N, Roso K, Chen LH, Greer PK, Keir ST, Mclendon RE, Cheng SY, Bigner DD, Ashley DM, Pirozzi CJ, He Y (2023) Repurposing clemastine to target glioblastoma cell stemness. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15184619","journal-title":"Cancers (Basel)"},{"key":"1640_CR251","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/bf02148852","volume":"38","author":"LB Svendsen","year":"1995","unstructured":"Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjaerg\u00e5rd J, Luke M, Stimpel H, Spars\u00f8 BH (1995) Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study. Dis Colon Rectum 38:514\u2013518. https:\/\/doi.org\/10.1007\/bf02148852","journal-title":"Dis Colon Rectum"},{"key":"1640_CR252","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/s1065-6995(02)90934-0","volume":"26","author":"N Szincs\u00e1k","year":"2002","unstructured":"Szincs\u00e1k N, Hegyesi H, Hunyadi J, Falus A, Juh\u00e1sz I (2002) Different h2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice. Cell Biol Int 26:833\u2013836. https:\/\/doi.org\/10.1016\/s1065-6995(02)90934-0","journal-title":"Cell Biol Int"},{"key":"1640_CR253","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1124\/mol.54.1.113","volume":"54","author":"M Taglialatela","year":"1998","unstructured":"Taglialatela M, Pannaccione A, Castaldo P, Giorgio G, Zhou Z, January CT, Genovese A, Marone G, Annunziato L (1998) Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol 54:113\u2013121. https:\/\/doi.org\/10.1124\/mol.54.1.113","journal-title":"Mol Pharmacol"},{"key":"1640_CR254","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2016.10.077","volume":"480","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, Sakaguchi M, Yoneyama H, Usami Y, Harusawa S (2016a) Histamine H(3) receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines. Biochem Biophys Res Commun 480:479\u2013485. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.077","journal-title":"Biochem Biophys Res Commun"},{"key":"1640_CR255","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8020025","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Kochi T, Shirakami Y, Mori T, Kurata A, Watanabe N, Moriwaki H, Shimizu M (2016b) Cimetidine and clobenpropit attenuate inflammation-associated colorectal carcinogenesis in male ICR mice. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers8020025","journal-title":"Cancers (Basel)"},{"key":"1640_CR256","first-page":"339","volume":"33","author":"TV Taylor","year":"1988","unstructured":"Taylor TV, Boom SJ, Blower AL, Mcmahon RF, Lawler W (1988) Healing of a malignant gastric ulcer with cimetidine. J R Coll Surg Edinb 33:339\u2013340","journal-title":"J R Coll Surg Edinb"},{"key":"1640_CR257","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC (2024) Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer 24:629\u2013646. https:\/\/doi.org\/10.1038\/s41568-024-00728-0","journal-title":"Nat Rev Cancer"},{"key":"1640_CR258","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3389\/fimmu.2018.01873","volume":"9","author":"EB Thangam","year":"2018","unstructured":"Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, Church MK, Saluja R (2018) The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Front Immunol 9:1873. https:\/\/doi.org\/10.3389\/fimmu.2018.01873","journal-title":"Front Immunol"},{"key":"1640_CR259","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2465","volume":"7","author":"RL Thurmond","year":"2008","unstructured":"Thurmond RL, Gelfand EW, Dunford PJ (2008) The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 7:41\u201353. https:\/\/doi.org\/10.1038\/nrd2465","journal-title":"Nat Rev Drug Discov"},{"key":"1640_CR260","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1517\/14728220903188438","volume":"18","author":"E Tiligada","year":"2009","unstructured":"Tiligada E, Zampeli E, Sander K, Stark H (2009) Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 18:1519\u20131531. https:\/\/doi.org\/10.1517\/14728220903188438","journal-title":"Expert Opin Investig Drugs"},{"key":"1640_CR261","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1254\/jphs.fp0040691","volume":"97","author":"K Tomita","year":"2005","unstructured":"Tomita K, Okabe S (2005) Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice. J Pharmacol Sci 97:116\u2013123. https:\/\/doi.org\/10.1254\/jphs.fp0040691","journal-title":"J Pharmacol Sci"},{"key":"1640_CR262","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1254\/jphs.93.321","volume":"93","author":"K Tomita","year":"2003","unstructured":"Tomita K, Izumi K, Okabe S (2003) Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice. J Pharmacol Sci 93:321\u2013330. https:\/\/doi.org\/10.1254\/jphs.93.321","journal-title":"J Pharmacol Sci"},{"key":"1640_CR263","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/s0140-6736(88)90743-x","volume":"2","author":"H T\u00f8nnesen","year":"1988","unstructured":"T\u00f8nnesen H, Knigge U, B\u00fclow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A, Pedersen IK, Pedersen VM, Siemssen OJ et al (1988) Effect of cimetidine on survival after gastric cancer. Lancet 2:990\u2013992. https:\/\/doi.org\/10.1016\/s0140-6736(88)90743-x","journal-title":"Lancet"},{"key":"1640_CR264","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/s1470-2045(20)30424-1","volume":"21","author":"AA Tran","year":"2020","unstructured":"Tran AA, Prasad V (2020) Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy. Lancet Oncol 21:1134\u20131136. https:\/\/doi.org\/10.1016\/s1470-2045(20)30424-1","journal-title":"Lancet Oncol"},{"key":"1640_CR265","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133\u2013146. https:\/\/doi.org\/10.1038\/nri1001","journal-title":"Nat Rev Immunol"},{"key":"1640_CR266","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244253","author":"E Trybus","year":"2024","unstructured":"Trybus E, Trybus W (2024) H1 antihistamines-promising candidates for repurposing in the context of the development of new therapeutic approaches to cancer treatment. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16244253","journal-title":"Cancers (Basel)"},{"key":"1640_CR267","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115890","author":"E Trybus","year":"2022","unstructured":"Trybus E, Kr\u00f3l T, Trybus W (2022) The multidirectional effect of azelastine hydrochloride on cervical cancer cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23115890","journal-title":"Int J Mol Sci"},{"key":"1640_CR268","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0192-0561(92)90107-v","volume":"14","author":"T Tsunoda","year":"1992","unstructured":"Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K (1992) In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients. Int J Immunopharmacol 14:75\u201381. https:\/\/doi.org\/10.1016\/0192-0561(92)90107-v","journal-title":"Int J Immunopharmacol"},{"key":"1640_CR269","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.21873\/anticanres.17645","volume":"45","author":"Y Uemichi","year":"2025","unstructured":"Uemichi Y, Yasuda S, Mabuchi M, Nakao S, Nagano S, Shimizu T (2025) Effects of azelastine on glioblastoma cells. Anticancer Res 45:2763\u20132771. https:\/\/doi.org\/10.21873\/anticanres.17645","journal-title":"Anticancer Res"},{"key":"1640_CR270","doi-asserted-by":"publisher","first-page":"111","DOI":"10.24953\/turkjpediatr.2005.2696","volume":"47","author":"A U\u011fuz","year":"2005","unstructured":"U\u011fuz A, Sanlio\u011flu S, Y\u00fczbey S, Co\u015fkun M, Ye\u011fin O (2005) The effect of cetirizine on IFN-gamma and IL-10 production in children with allergic rhinitis. Turk J Pediatr 47:111\u2013115","journal-title":"Turk J Pediatr"},{"key":"1640_CR271","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.180037","author":"J Van Den Bulk","year":"2018","unstructured":"Van Den Bulk J, Verdegaal EM, De Miranda NF (2018) Cancer immunotherapy: broadening the scope of targetable tumours. Open Biol. https:\/\/doi.org\/10.1098\/rsob.180037","journal-title":"Open Biol"},{"key":"1640_CR272","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jaci.2010.12.002","volume":"127","author":"B Vanbervliet","year":"2011","unstructured":"Vanbervliet B, Akdis M, Vocanson M, Rozi\u00e8res A, Beneti\u00e8re J, Rouzaire P, Akdis CA, Nicolas JF, Hennino A (2011) Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-\u03b3\/IL-17 balance in T cell-mediated skin inflammation. J Allergy Clin Immunol 127:943\u201353.e1-10. https:\/\/doi.org\/10.1016\/j.jaci.2010.12.002","journal-title":"J Allergy Clin Immunol"},{"key":"1640_CR273","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12032-023-02117-3","volume":"40","author":"S Vidicevic-Novakovic","year":"2023","unstructured":"Vidicevic-Novakovic S, Stanojevic Z, Tomonjic N, Karapandza K, Zekovic J, Martinovic T, Grujicic D, Ilic R, Raicevic S, Tasic J, Isakovic A (2023) Proapoptotic and proautophagy effect of H1-receptor antagonist desloratadine in human glioblastoma cell lines. Med Oncol 40:241. https:\/\/doi.org\/10.1007\/s12032-023-02117-3","journal-title":"Med Oncol"},{"key":"1640_CR274","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1151591","volume":"5","author":"A Vila-Leahey","year":"2016","unstructured":"Vila-Leahey A, Oldford SA, Marignani PA, Wang J, Haidl ID, Marshall JS (2016a) Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice. Oncoimmunology 5:e1151591. https:\/\/doi.org\/10.1080\/2162402x.2016.1151591","journal-title":"Oncoimmunology"},{"key":"1640_CR275","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.18632\/oncotarget.7211","volume":"7","author":"A Vila-Leahey","year":"2016","unstructured":"Vila-Leahey A, Rogers D, Marshall JS (2016b) The impact of ranitidine on monocyte responses in the context of solid tumors. Oncotarget 7:10891\u201310904. https:\/\/doi.org\/10.18632\/oncotarget.7211","journal-title":"Oncotarget"},{"key":"1640_CR276","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.21873\/invivo.13190","volume":"37","author":"F Villarruel-Melquiades","year":"2023","unstructured":"Villarruel-Melquiades F, Hernandez-Gallegos E, Solano-Agama C, Mendoza-Garrido ME, Camacho J (2023) The combination sorafenib-raloxifene-loratadine as a novel potential therapeutic approach against human liver cancer. In Vivo 37:1156\u20131163. https:\/\/doi.org\/10.21873\/invivo.13190","journal-title":"In Vivo"},{"key":"1640_CR277","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.metabol.2009.02.011","volume":"58","author":"J Von Mach-Szczypi\u0144ski","year":"2009","unstructured":"Von Mach-Szczypi\u0144ski J, Stanosz S, Sieja K, Stanosz M (2009) Metabolism of histamine in tissues of primary ductal breast cancer. Metabolism 58:867\u2013870. https:\/\/doi.org\/10.1016\/j.metabol.2009.02.011","journal-title":"Metabolism"},{"key":"1640_CR278","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/ijmm.2014.1649","volume":"33","author":"M Wang","year":"2014","unstructured":"Wang M, Wei X, Shi L, Chen B, Zhao G, Yang H (2014a) Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction. Int J Mol Med 33:1019\u20131026. https:\/\/doi.org\/10.3892\/ijmm.2014.1649","journal-title":"Int J Mol Med"},{"key":"1640_CR279","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-013-0912-x","volume":"387","author":"WT Wang","year":"2014","unstructured":"Wang WT, Chen YH, Hsu JL, Leu WJ, Yu CC, Chan SH, Ho YF, Hsu LC, Guh JH (2014b) Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation. Naunyn Schmiedebergs Arch Pharmacol 387:33\u201345. https:\/\/doi.org\/10.1007\/s00210-013-0912-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1640_CR280","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/bjc.2014.598","volume":"112","author":"Z Wang","year":"2015","unstructured":"Wang Z, Mcloone P, Morrison DS (2015) Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals. Br J Cancer 112:572\u2013575. https:\/\/doi.org\/10.1038\/bjc.2014.598","journal-title":"Br J Cancer"},{"key":"1640_CR281","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912469","author":"CH Wang","year":"2022","unstructured":"Wang CH, Chen II, Chen CH, Tseng YT (2022) Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study. Int J Environ Res Public Health. 19: 12469\u00a0https:\/\/doi.org\/10.3390\/ijerph191912469","journal-title":"Int J Environ Res Public Health"},{"key":"1640_CR282","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goaf090","author":"X Wang","year":"2025","unstructured":"Wang X, Sheng G, Yan Z, Shi A, Liu Z, Tang Y, Li G, Zhang Z (2025) Function of histamine-driven cancer-associated fibroblast and hepatocyte growth factor in the progression of cholangiocarcinoma. Gastroenterol Rep. https:\/\/doi.org\/10.1093\/gastro\/goaf090","journal-title":"Gastroenterol Rep"},{"key":"1640_CR283","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/carcin\/21.6.1149","volume":"21","author":"MJ Wargovich","year":"2000","unstructured":"Wargovich MJ, Jimenez A, Mckee K, Steele VE, Velasco M, Woods J, Price R, Gray K, Kelloff GJ (2000) Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21:1149\u20131155","journal-title":"Carcinogenesis"},{"key":"1640_CR284","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.34.8.1091","volume":"34","author":"SA Watson","year":"1993","unstructured":"Watson SA, Wilkinson LJ, Robertson JF, Hardcastle JD (1993) Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 34:1091\u20131096. https:\/\/doi.org\/10.1136\/gut.34.8.1091","journal-title":"Gut"},{"key":"1640_CR285","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1365-2168.1997.02761.x","volume":"84","author":"HA Wotherspoon","year":"1997","unstructured":"Wotherspoon HA, Anderson JR, Morran CG, Murray GD, Mcardle CS (1997) Randomized controlled trial of an H2-receptor antagonist in gastric cancer. Br J Surg 84:1168\u20131169. https:\/\/doi.org\/10.1046\/j.1365-2168.1997.02761.x","journal-title":"Br J Surg"},{"key":"1640_CR286","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L (2024) Drug repurposing for cancer therapy. Signal Transduct Target Ther 9:92. https:\/\/doi.org\/10.1038\/s41392-024-01808-1","journal-title":"Signal Transduct Target Ther"},{"key":"1640_CR287","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","volume":"24","author":"Y Xie","year":"2025","unstructured":"Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q, Dong Z, Liu K (2025) Inflammation in cancer: therapeutic opportunities from new insights. Mol Cancer 24:51. https:\/\/doi.org\/10.1186\/s12943-025-02243-8","journal-title":"Mol Cancer"},{"key":"1640_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2024.100464","author":"YS Xu","year":"2025","unstructured":"Xu YS (2025) Terfenadine exhibits antineoplastic effects on patient-derived organoids of cervical adenocarcinoma via PI3K\/AKT pathway. Int J Gynecol Cancer. https:\/\/doi.org\/10.1016\/j.ijgc.2024.100464","journal-title":"Int J Gynecol Cancer"},{"key":"1640_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189146","volume":"1879","author":"P Yadav","year":"2024","unstructured":"Yadav P, Vengoji R, Jain M, Batra SK, Shonka N (2024) Pathophysiological role of histamine signaling and its implications in glioblastoma. Biochim Biophys Acta Rev Cancer 1879:189146. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189146","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1640_CR290","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1039\/d2cs00116k","volume":"51","author":"J Yamamoto","year":"2022","unstructured":"Yamamoto J, Ito T, Yamaguchi Y, Handa H (2022) Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders. Chem Soc Rev 51:6234\u20136250. https:\/\/doi.org\/10.1039\/d2cs00116k","journal-title":"Chem Soc Rev"},{"key":"1640_CR291","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.2278","volume":"17","author":"XD Yang","year":"2011","unstructured":"Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, Park H, Shykind B, Diacovo TG, Falus A, Wang TC (2011) Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med 17:87\u201395. https:\/\/doi.org\/10.1038\/nm.2278","journal-title":"Nat Med"},{"key":"1640_CR292","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1007\/s00432-023-04698-y","volume":"149","author":"F Yao","year":"2023","unstructured":"Yao F, An Y, Lai X, Li X, Yu Z, Yang XD (2023) Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine. J Cancer Res Clin Oncol 149:7515\u20137527. https:\/\/doi.org\/10.1007\/s00432-023-04698-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"1640_CR293","first-page":"1794","volume":"30","author":"K Yoshimatsu","year":"2003","unstructured":"Yoshimatsu K, Ishibashi K, Hashimoto M, Umehara A, Yokomizo H, Yoshida K, Fujimoto T, Iwasaki K, Ogawa K (2003) Effect of cimetidine with chemotherapy on stage IV colorectal cancer. Gan to Kagaku Ryoho 30:1794\u20131797","journal-title":"Gan to Kagaku Ryoho"},{"key":"1640_CR294","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.21873\/anticanres.15449","volume":"41","author":"K Yoshino","year":"2021","unstructured":"Yoshino K, Okamoto I, Sato H, Okada T, Tokashiki K, Kondo T, Tsukahara K (2021) Effect of concomitant lafutidine on adjuvant S-1 for head and neck cancer: a comparative study. Anticancer Res 41:6279\u20136285. https:\/\/doi.org\/10.21873\/anticanres.15449","journal-title":"Anticancer Res"},{"key":"1640_CR295","doi-asserted-by":"publisher","first-page":"e2333495","DOI":"10.1001\/jamanetworkopen.2023.33495","volume":"6","author":"SC You","year":"2023","unstructured":"You SC, Seo SI, Falconer T, Yanover C, Duarte-Salles T, Seager S, Posada JD, Shah NH, Nguyen PA, Kim Y, Hsu JC, Van Zandt M, Hsu MH, Lee HL, Ko H, Shin WG, Pratt N, Park RW, Reich CG, Suchard MA, Hripcsak G, Park CH, Prieto-Alhambra D (2023) Ranitidine use and incident cancer in a multinational cohort. JAMA Netw Open 6:e2333495. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.33495","journal-title":"JAMA Netw Open"},{"key":"1640_CR296","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3892\/or.2019.7119","volume":"41","author":"D Yu","year":"2019","unstructured":"Yu D, Zhao J, Wang Y, Hu J, Zhao Q, Li J, Zhu J (2019) Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma. Oncol Rep 41:3347\u20133354. https:\/\/doi.org\/10.3892\/or.2019.7119","journal-title":"Oncol Rep"},{"key":"1640_CR297","doi-asserted-by":"publisher","first-page":"967","DOI":"10.31925\/farmacia.2021.5.21","volume":"69","author":"RUI Zhang","year":"2021","unstructured":"Zhang RUI (2021) Anticancer activity of diphenhydramine against pancreatic cancer by stimulating cell cycle arrest, apoptosis, and modulation of PI3K\/Akt\/mTOR pathway. Farmacia 69:967\u2013973. https:\/\/doi.org\/10.31925\/farmacia.2021.5.21","journal-title":"Farmacia"},{"key":"1640_CR298","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031207","volume":"7","author":"C Zhang","year":"2012","unstructured":"Zhang C, Xiong Y, Li J, Yang Y, Liu L, Wang W, Wang L, Li M, Fang Z (2012) Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. PLoS ONE 7:e31207. https:\/\/doi.org\/10.1371\/journal.pone.0031207","journal-title":"PLoS ONE"},{"key":"1640_CR299","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1080\/21645515.2016.1191719","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Chen Z, Luo X, Wu B, Li B, Wang B (2016) Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells. Hum Vaccin Immunother 12:2512\u20132518. https:\/\/doi.org\/10.1080\/21645515.2016.1191719","journal-title":"Hum Vaccin Immunother"},{"key":"1640_CR300","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.2147\/OTT.S250655","volume":"13","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yu Y, Ma L, Fu P (2020a) Histamine H3 receptor promotes cell survival via regulating PKA\/CREB\/CDKN1A signal pathway in hepatocellular carcinoma. Onco Targets Ther 13:3765\u20133776. https:\/\/doi.org\/10.2147\/OTT.S250655","journal-title":"Onco Targets Ther"},{"key":"1640_CR301","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C (2020b) Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 5:113. https:\/\/doi.org\/10.1038\/s41392-020-00213-8","journal-title":"Signal Transduct Target Ther"},{"key":"1640_CR302","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8909631","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li X, Xie J, Zhu Q, Yuan Y (2022) A novel immune-related prognostic signature predicting survival in patients with pancreatic adenocarcinoma. J Oncol. https:\/\/doi.org\/10.1155\/2022\/8909631","journal-title":"J Oncol"},{"key":"1640_CR303","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.21037\/tlcr-24-795","volume":"13","author":"WH Zhang","year":"2024","unstructured":"Zhang WH, Li BX, Ma CX, Wang J, Yang F, Xiong YJ, Li SZ, Zhang JL, Du WJ, Hui ZZ, Shen M, Zhou L, Li RM, Tian X, Han Y, Ren BZ, Ichiki Y, Lee SC, Zhang XW, Cao S, Ren XB, Liu L (2024) Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study. Transl Lung Cancer Res 13:2787\u20132801. https:\/\/doi.org\/10.21037\/tlcr-24-795","journal-title":"Transl Lung Cancer Res"},{"key":"1640_CR304","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/s41388-019-1093-y","volume":"39","author":"J Zhao","year":"2020","unstructured":"Zhao J, Hou Y, Yin C, Hu J, Gao T, Huang X, Zhang X, Xing J, An J, Wan S, Li J (2020) Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene 39:1724\u20131738. https:\/\/doi.org\/10.1038\/s41388-019-1093-y","journal-title":"Oncogene"},{"key":"1640_CR305","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41401-020-00548-6","volume":"42","author":"YY Zhao","year":"2021","unstructured":"Zhao YY, Jia J, Zhang JJ, Xun YP, Xie SJ, Liang JF, Guo HG, Zhu JZ, Ma SL, Zhang SR (2021) Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K\/Akt\/mTOR and MEK\/ERK signaling pathways and blocking EMT. Acta Pharmacol Sin 42:1288\u20131297. https:\/\/doi.org\/10.1038\/s41401-020-00548-6","journal-title":"Acta Pharmacol Sin"},{"key":"1640_CR306","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03060-5","volume":"43","author":"P Zhong","year":"2024","unstructured":"Zhong P, Nakata K, Oyama K, Higashijima N, Sagara A, Date S, Luo H, Hayashi M, Kubo A, Wu C, He S, Yamamoto T, Koikawa K, Iwamoto C, Abe T, Ikenaga N, Ohuchida K, Morisaki T, Oda Y, Kuba K, Nakamura M (2024) Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. J Exp Clin Cancer Res 43:138. https:\/\/doi.org\/10.1186\/s13046-024-03060-5","journal-title":"J Exp Clin Cancer Res"},{"key":"1640_CR307","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","volume":"38","author":"J Zugazagoitia","year":"2016","unstructured":"Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016) Current challenges in cancer treatment. Clin Ther 38:1551\u20131566. https:\/\/doi.org\/10.1016\/j.clinthera.2016.03.026","journal-title":"Clin Ther"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-026-01640-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:48:33Z","timestamp":1792640913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-026-01640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":307,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s12272-026-01640-x","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chun KS is the Associate Editor of this journal, Archives of Pharmacal Research. However, his position did not influence the editorial decision or the peer review process of this manuscript. Any other authors declared no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}